Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Colorectal Neoplasms

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 487 articles:
HTML format



Single Articles


    June 2024
  1. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
    Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
    Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15539.
    PubMed     Abstract available


  2. SHIN JK, Kim HC
    ASO Author Reflections: Robotic Surgery is Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy.
    Ann Surg Oncol. 2024;31:3959-3960.
    PubMed    


  3. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
    ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:3787-3788.
    PubMed    


  4. KAMDEM L, Asmar AE, Demetter P, Zana IC, et al
    Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:3778-3784.
    PubMed     Abstract available


  5. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
    Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
    Ann Surg Oncol. 2024;31:3758-3768.
    PubMed     Abstract available


  6. PIKOULIS E, Beyer K, Kreis ME, Pawlik TM, et al
    ASO Author Reflections: Surgical Technique for Colorectal Liver Metastases: Biology is King, but the Princes and Princesses (Surgical Techniques) also Matter.
    Ann Surg Oncol. 2024;31:4046-4047.
    PubMed    


    May 2024
  7. HUANG Y, Liao F, Chen H, Shu X, et al
    ASO Author Reflections: Self-expanding Metal Stents for Right-Sided Colonic Cancer Obstruction.
    Ann Surg Oncol. 2024;31:3242-3243.
    PubMed    


  8. GOMAA I, Aboelmaaty S, Narasimhan AL, Bhatt H, et al
    The Impact of Enhanced Recovery on Long-Term Survival in Rectal Cancer.
    Ann Surg Oncol. 2024;31:3233-3241.
    PubMed     Abstract available


  9. ONO Y, Inoue Y, Ito H, Takahashi Y, et al
    ASO Author Reflections: Advancing Two-Stage Hepatectomy: Laparoscopic Portal Vein Ligation and Embolization for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:3114-3115.
    PubMed    


  10. HUANG Y, Liao F, Zhan Z, Chen X, et al
    Efficacy and Safety Analysis of Emergency Endoscopic Self-Expanding Metal Stent Placement Without Fluoroscopic Assistance for Right-Sided Colonic Cancer Obstruction.
    Ann Surg Oncol. 2024;31:3212-3221.
    PubMed     Abstract available


  11. GORJI L, Nikahd M, Onuma A, Tsilimigras D, et al
    Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
    Ann Surg Oncol. 2024;31:3389-3396.
    PubMed     Abstract available


  12. SHIN JK, Kim HC, Lee WY, Yun SH, et al
    Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?
    Ann Surg Oncol. 2024;31:3203-3211.
    PubMed     Abstract available


  13. FACKCHE NT, Schmocker RK, Nudotor R, Kubi B, et al
    Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
    Ann Surg Oncol. 2024;31:3314-3324.
    PubMed     Abstract available


  14. ONO Y, Inoue Y, Kobayashi K, Sato S, et al
    Laparoscopic Portal Vein Ligation and Embolization During First-Stage Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:3069-3070.
    PubMed     Abstract available


    April 2024
  15. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    Disparities in Colorectal Cancer Screening.
    Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15296.
    PubMed    


  16. BEKKI T, Shimomura M, Yano T, Akabane S, et al
    Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
    Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300.
    PubMed    


  17. KHAN MMM, Munir MM, Khalil M, Pawlik TM, et al
    Reply to: Colorectal Cancer Screening and Social Vulnerability Index: Impact of COVID-19 Pandemic.
    Ann Surg Oncol. 2024 Apr 23. doi: 10.1245/s10434-024-15302.
    PubMed    


  18. YANG Y, Du Z, Zhang Q
    Letter to Editor regarding article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
    Ann Surg Oncol. 2024 Apr 10. doi: 10.1245/s10434-024-15263.
    PubMed    


  19. BOYEV A, Newhook TE
    ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival.
    Ann Surg Oncol. 2024;31:2600-2601.
    PubMed    


  20. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
    ASO Author Reflections: Advancements in Laparoscopic Parenchyma-Sparing Liver Resection: Autologous Peritoneal Patch for Middle Hepatic Vein Reconstruction in Colorectal Liver Metastasis.
    Ann Surg Oncol. 2024;31:2598-2599.
    PubMed    


  21. CHOI JS, Kim MJ, Shin R, Park JW, et al
    ASO Visual Abstract: Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumor: Who Needs a Radical Resection for the Rectal Neuroendocrine Tumor 1-2 cm in Size?
    Ann Surg Oncol. 2024;31:2439.
    PubMed    


  22. WACH MM, Nunns G, Hamed A, Derby J, et al
    Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:2391-2400.
    PubMed     Abstract available


  23. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
    Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
    Ann Surg Oncol. 2024;31:2425-2438.
    PubMed     Abstract available


  24. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
    ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:2606.
    PubMed    


  25. SULLIVAN KM, Whelan RL, DePeralta D, Merchea A, et al
    Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the US
    Ann Surg Oncol. 2024;31:2408-2409.
    PubMed    


  26. HIRST N, McBride K, Steffens D
    Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal?
    Ann Surg Oncol. 2024;31:2183-2186.
    PubMed    


  27. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
    ASO Visual Abstract: Double Negativity of MRI-Detected and Pathologically Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
    Ann Surg Oncol. 2024;31:2440-2441.
    PubMed    


  28. CHOI JS, Kim MJ, Shin R, Park JW, et al
    Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Ann Surg Oncol. 2024;31:2414-2424.
    PubMed     Abstract available


  29. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
    Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:2547-2556.
    PubMed     Abstract available


  30. CHIU CC
    Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter P
    Ann Surg Oncol. 2024;31:2405-2407.
    PubMed    


    March 2024
  31. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
    ASO Visual Abstract: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15140.
    PubMed    


  32. BEDRIKOVETSKI S, Traeger L, Fitzsimmons T, Price TJ, et al
    ASO Visual Abstract: Association Between RAS/BRAF Mutations and Complete Response After Total Neoadjuvant Therapy of Patients with Rectal Cancer: A Prospective Multicentered Study.
    Ann Surg Oncol. 2024;31:1698-1699.
    PubMed    


  33. RADOMSKI SN, Dunworth M, West JJ, Greer JB, et al
    Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers.
    Ann Surg Oncol. 2024;31:1996-2007.
    PubMed     Abstract available


  34. PIKOULIS E, Papaconstantinou D, Pikouli A, Pararas N, et al
    Is Precision Surgery Applicable to Colorectal Liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor Biology.
    Ann Surg Oncol. 2024;31:1823-1832.
    PubMed     Abstract available


  35. BEDRIKOVETSKI S, Traeger L, Sammour T
    ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer.
    Ann Surg Oncol. 2024;31:1692-1693.
    PubMed    


  36. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National Prospective Cohort Study.
    Ann Surg Oncol. 2024;31:1959-1969.
    PubMed     Abstract available


  37. CIFTCI Y, Radomski SN, Johnston FM, Greer JB, et al
    ASO Visual Abstract: Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
    Ann Surg Oncol. 2024;31:2016.
    PubMed    


  38. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    ASO Visual Abstract: Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National Prospective Cohort Study.
    Ann Surg Oncol. 2024;31:2014-2015.
    PubMed    


  39. MIRZA MB, Smith PM, Wang Y, Naveed A, et al
    Intra-Patient Heterogeneity in Micro-satellite-stable Colorectal Metastases: Does Immunotherapy Have a Role in Colorectal Peritoneal Metastases?
    Ann Surg Oncol. 2024;31:1440-1443.
    PubMed    


  40. SARFATY E, Khajoueinejad N, Yu AT, Hiotis S, et al
    ASO Visual Abstract: Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:2021.
    PubMed    


  41. BEDRIKOVETSKI S, Traeger L, Fitzsimmons T, Price TJ, et al
    Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.
    Ann Surg Oncol. 2024;31:1681-1689.
    PubMed     Abstract available


  42. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    ASO Author Reflections: Biopsychosocial Late Effects are Frequent and Negatively Impact Quality of Life Following Curatively Intended Surgery for Colorectal and Appendiceal Cancer with Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:1696-1697.
    PubMed    


  43. SARFATY E, Cohen NA
    ASO Author Reflections: Achieving Long-Term Survival in Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:2010-2011.
    PubMed    


  44. WU CY, Ye K
    The Application Prospect of Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer is Broad.
    Ann Surg Oncol. 2024;31:1702-1703.
    PubMed    


  45. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
    Novel Use of the Falciform Ligament for MHV Reconstruction During Laparoscopic Hepatectomy of Colorectal Liver Metastasis.
    Ann Surg Oncol. 2024;31:1835.
    PubMed     Abstract available


  46. RYU S, Goto K, Imaizumi Y, Nakabayashi Y, et al
    Laparoscopic Colorectal Surgery with Anatomical Recognition with Artificial Intelligence Assistance for Nerves and Dissection Layers.
    Ann Surg Oncol. 2024;31:1690-1691.
    PubMed     Abstract available


  47. KOSEKI Y, Hikage M, Terashima M, Notsu A, et al
    ASO Visual Abstract: The Effectiveness of Screening Total Colonoscopy for Preoperative Patients with Gastric Cancer.
    Ann Surg Oncol. 2024;31:1800-1801.
    PubMed    


  48. SARFATY E, Khajoueinejad N, Yu AT, Hiotis S, et al
    Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:1970-1979.
    PubMed     Abstract available


  49. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    ASO Visual Abstract: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
    Ann Surg Oncol. 2024;31:2017-2018.
    PubMed    


  50. TONELLO M, Sommariva A
    ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.
    Ann Surg Oncol. 2024;31:2008-2009.
    PubMed    


    February 2024
  51. KHAN MMM, Munir MM, Pawlik TM
    ASO Author Reflections: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Feb 21. doi: 10.1245/s10434-024-15097.
    PubMed    


  52. MEIER J, Murimwa G, Nehrubabu M, DiMartino L, et al
    ASO Visual Abstract: Effect of Hospital Cancer Designation on Use of Multimodal Therapy and Survival of Patients with Metastatic Colorectal Cancer: A State-Wide Analysis.
    Ann Surg Oncol. 2024 Feb 17. doi: 10.1245/s10434-024-15015.
    PubMed    


  53. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
    Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Feb 15. doi: 10.1245/s10434-024-15029.
    PubMed     Abstract available


  54. MCDONALD HG, Zaki OA, Wright MJ, Jayswal R, et al
    Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers.
    Ann Surg Oncol. 2024;31:1252-1263.
    PubMed     Abstract available


  55. DIAZ A, Pawlik T
    Association of ICD-10 Clinical Modification Codes for Social Determinants of Health with Surgical Outcomes and Hospital Charges Among Cancer Patients.
    Ann Surg Oncol. 2024;31:1171-1177.
    PubMed     Abstract available


  56. TIPMANEE P, Malakorn S
    Laparoscopic Total Pelvic Exenteration with En-bloc Lateral Pelvic Lymph Node Dissection with Colonic Flap Pelvic Reconstruction.
    Ann Surg Oncol. 2024;31:1087-1088.
    PubMed    


  57. KOSEKI Y, Hikage M, Terashima M, Notsu A, et al
    The Effectiveness of Screening Total Colonoscopy for Preoperative Patients with Gastric Cancer.
    Ann Surg Oncol. 2024;31:762-771.
    PubMed     Abstract available


    January 2024
  58. GRANGE R, Rousset P, Williet N, Guesnon M, et al
    ASO Visual Abstract: Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
    Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14923.
    PubMed    


  59. BEKKI T, Shimomura M, Hattori M, Sato S, et al
    C-Reactive Protein/Albumin Ratio Is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients.
    Ann Surg Oncol. 2024 Jan 27. doi: 10.1245/s10434-024-14961.
    PubMed     Abstract available


  60. MEIER J, Murimwa G, Nehrubabu M, DiMartino L, et al
    Effect of Hospital Cancer Designation on use of Multimodal Therapy and Survival of Metastatic Colorectal Cancer: A State-Wide Analysis.
    Ann Surg Oncol. 2024 Jan 20. doi: 10.1245/s10434-023-14859.
    PubMed     Abstract available


  61. KEPENEKIAN V, Grange R, Passot G, Glehen O, et al
    ASO Author Reflections: Selected Multisite Metastatic Colorectal Cancer Patients May Benefit from Radical Multimodal Treatment.
    Ann Surg Oncol. 2024 Jan 19. doi: 10.1245/s10434-024-14929.
    PubMed    


  62. DEGIULI M, Aguilar HAR, Solej M, Azzolina D, et al
    ASO Visual Abstract: A Randomized Phase III Trial of Complete Mesocolic Excision in Comparison with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal
    Ann Surg Oncol. 2024 Jan 10. doi: 10.1245/s10434-023-14794.
    PubMed    


  63. GRANGE R, Rousset P, Williet N, Guesnon M, et al
    Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
    Ann Surg Oncol. 2024 Jan 3. doi: 10.1245/s10434-023-14840.
    PubMed     Abstract available


  64. SARKAR J, Attwood K, Schwarz RE
    ASO Visual Abstract: Perioperative Chemotherapy is Associated with Superior Overall Survival in Patients with Synchronous Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:158.
    PubMed    


  65. THOMAS KK, Francescatti AB, Vreeland TJ, Teshome MK, et al
    Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6.
    Ann Surg Oncol. 2024;31:6-9.
    PubMed     Abstract available


  66. SARKAR J, Schwarz RE
    ASO Author Reflections: Optimizing Treatment Sequencing in Synchronous Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:156-157.
    PubMed    


  67. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
    Ann Surg Oncol. 2024;31:594-604.
    PubMed     Abstract available


  68. BRANES A, Karanicolas P
    Adjuvant Hepatic Artery Infusion Chemotherapy: Still Swimming in Dark Water?
    Ann Surg Oncol. 2024;31:19-20.
    PubMed    


  69. VIERRA M, Bansal VV, Morgan RB, Witmer HDD, et al
    ASO Visual Abstract: Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:657-658.
    PubMed    


  70. VIERRA M, Bansal VV, Shergill A, Turaga KK, et al
    ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:655-656.
    PubMed    


  71. VIERRA M, Bansal VV, Morgan RB, Witmer HDD, et al
    Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:645-654.
    PubMed     Abstract available


    December 2023
  72. DEGIULI M, Aguilar AHR, Solej M, Azzolina D, et al
    A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in tr
    Ann Surg Oncol. 2023 Dec 12. doi: 10.1245/s10434-023-14664.
    PubMed     Abstract available


  73. DEGIULI M, Azzolina D, Corcione F, Bracale U, et al
    ASO Author Reflections: Complete Mesocolic Excision Versus Conventional Surgery for Right Colon Cancer (CoME-in trial): An Interim Analysis of a Multicenter, Randomized, Controlled Trial.
    Ann Surg Oncol. 2023 Dec 12. doi: 10.1245/s10434-023-14771.
    PubMed    


  74. BUCHHEIT JT, Merkow RP
    ASO Author Reflections: Disparities in Colon Cancer Outcomes Exist Irrespective of Hospital Performance-System-Wide Changes Are Needed to Help Close the Gap.
    Ann Surg Oncol. 2023 Dec 12. doi: 10.1245/s10434-023-14706.
    PubMed    


  75. SAWADA A, Ohira M, Hatanaka KC, Matsui H, et al
    Expression Analysis of Early Metastatic Seeding of Colorectal Cancer.
    Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14714.
    PubMed     Abstract available


  76. BUCHHEIT JT, Silver CM, Huang R, Hu YY, et al
    ASO Visual Abstract: Association Between Racial and Socioeconomic Disparities and Hospital Performance in Treatment and Outcomes for Patients with Colon Cancer.
    Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14743.
    PubMed    


  77. BUCHHEIT JT, Silver CM, Huang R, Hu YY, et al
    Association Between Racial and Socioeconomic Disparities and Hospital Performance in Treatment and Outcomes for Patients with Colon Cancer.
    Ann Surg Oncol. 2023 Dec 7. doi: 10.1245/s10434-023-14607.
    PubMed     Abstract available


  78. KOSEKI Y, Hikage M, Terashima M, Notsu A, et al
    ASO Author Reflections: Significance of Colorectal Cancer Screening Through Preoperative Total Colonoscopy for Gastric Cancer.
    Ann Surg Oncol. 2023 Dec 4. doi: 10.1245/s10434-023-14641.
    PubMed    


  79. FILIPE WF, Meyer YM, Buisman FE, van den Braak RRJC, et al
    The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.
    Ann Surg Oncol. 2023;30:7996-8005.
    PubMed     Abstract available


  80. SARKAR J, Attwood K, Schwarz RE
    Perioperative Chemotherapy is Associated with Superior Overall Survival in Patients with Synchronous Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:7986-7995.
    PubMed     Abstract available


  81. STANDRING O, Gholami S
    First-line Hepatic Artery Infusion for Unresectable CLM Works, but Will We Ever Get There?
    Ann Surg Oncol. 2023;30:7918-7920.
    PubMed    


  82. JUDGE SJ, Ghalambor T, Cavnar MJ, Lidsky ME, et al
    ASO Visual Abstract: Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy-An International Survey of the HAI Consortium Research Network.
    Ann Surg Oncol. 2023;30:8021-8022.
    PubMed    


  83. SUN BJ, Yue TM, Xu N, Fowler C, et al
    ASO Visual Abstract: Impact of Successful Implementation of an Enhanced Recovery After Surgery (ERAS) Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
    Ann Surg Oncol. 2023;30:8177.
    PubMed    


  84. ENGLUM BR, Sahoo S, Mayorga-Carlin M, Hayssen H, et al
    Growing Deficit in New Cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study.
    Ann Surg Oncol. 2023;30:8509-8518.
    PubMed     Abstract available


  85. SUN BJ, Yue TM, Xu N, Fowler C, et al
    Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2023;30:8156-8165.
    PubMed     Abstract available


  86. WU H, Ma W, Jiang C, Li N, et al
    Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy.
    Ann Surg Oncol. 2023;30:8572-8587.
    PubMed     Abstract available


  87. VERHEIJ FS, Kuhlmann KFD, Silliman DR, Soares KC, et al
    ASO Visual Abstract: Combined Hepatic Artery Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:8014-8015.
    PubMed    


  88. VERHEIJ FS, Kuhlmann KFD, Silliman DR, Soares KC, et al
    Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:7950-7959.
    PubMed     Abstract available


    November 2023
  89. WEHRLE CJ, Fujiki M, Schlegel A, Whitsett Linganna M, et al
    Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'.
    Ann Surg Oncol. 2023 Nov 23. doi: 10.1245/s10434-023-14611.
    PubMed     Abstract available


  90. TRAN CG, Goffredo P, Mott SL, Suraju MO, et al
    ASO Visual Abstract: Conditional Survival After Diagnosis of Non-metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status.
    Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14599.
    PubMed    


  91. HUBNER M, van Der Speeten K, Govaerts K, de Hingh I, et al
    2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer.
    Ann Surg Oncol. 2023 Nov 8. doi: 10.1245/s10434-023-14368.
    PubMed     Abstract available


  92. WEHRLE CJ, Seavey CN, Chang J, Stackhouse K, et al
    Neoadjuvant Gastric Score: How Response to Neoadjuvant Chemotherapy Affects Overall Survival and Adjuvant Benefit.
    Ann Surg Oncol. 2023;30:7240-7250.
    PubMed     Abstract available


  93. KUBOTA S, Miura T, Wakiya T, Yoshizawa T, et al
    ASO Visual Abstract: Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions.
    Ann Surg Oncol. 2023;30:7639-7640.
    PubMed    


  94. SEGURA-SAMPEDRO JJ, Morales-Soriano R, Rodriguez-Pino JC, Pineno Flores C, et al
    Antiperistaltic Transverse Coloplasty: A Salvage Procedure in Extensive Bowel and Colorectal Resections to Avoid Intestinal Failure.
    Ann Surg Oncol. 2023;30:7236-7239.
    PubMed     Abstract available


  95. WINICKI NM, Radomski SN, Florissi IS, Cloyd JM, et al
    Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
    Ann Surg Oncol. 2023;30:7840-7847.
    PubMed     Abstract available


  96. RAOOF M, Whelan RL, Sullivan KM, Ruel C, et al
    ASO Visual Abstract: Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the United States.
    Ann Surg Oncol. 2023;30:7869-7870.
    PubMed    


  97. KUBOTA S, Miura T, Wakiya T, Yoshizawa T, et al
    Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions.
    Ann Surg Oncol. 2023;30:7612-7623.
    PubMed     Abstract available


  98. KOBAYASHI K, Ono Y, Kitano Y, Oba A, et al
    Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
    Ann Surg Oncol. 2023;30:7338-7347.
    PubMed     Abstract available


  99. GOFFREDO P, Tran CG, Hassan I
    ASO Author Reflections: Tailoring Surveillance to Tumor Biology: KRAS and Conditional Survival in Colon Cancer.
    Ann Surg Oncol. 2023 Nov 1. doi: 10.1245/s10434-023-14537.
    PubMed    


  100. RAOOF M, Whelan RL, Sullivan KM, Ruel C, et al
    Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
    Ann Surg Oncol. 2023;30:7814-7824.
    PubMed     Abstract available


  101. SOLBAKKEN AM, Sellevold S, Spasojevic M, Julsrud L, et al
    Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer.
    Ann Surg Oncol. 2023;30:7602-7611.
    PubMed     Abstract available


  102. JUDGE SJ, Ghalambor T, Cavnar MJ, Lidsky ME, et al
    Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network.
    Ann Surg Oncol. 2023;30:7362-7370.
    PubMed     Abstract available


    October 2023
  103. SONAL S, Jain B, Bajaj SS, Dee EC, et al
    Trends and Determinants of Location of Death Due to Colorectal Cancer in the United States : A Nationwide Study.
    Ann Surg Oncol. 2023 Oct 31. doi: 10.1245/s10434-023-14337.
    PubMed     Abstract available


  104. ZHENG X, Cen W, Zhu J, Ye L, et al
    ASO Visual Abstract: Prognostic Value of Tumor Deposits in Stage III Colorectal Cancer Patients with Different N stages: A Population-Based, Retrospective, Cohort Study.
    Ann Surg Oncol. 2023 Oct 30. doi: 10.1245/s10434-023-14480.
    PubMed    


  105. SONAL S, Jain B, Bajaj SS, Dee EC, et al
    ASO Visual Abstract: Trends and Determinants of Location of Death Due to Colorectal Cancer in the USA: A Nationwide Study.
    Ann Surg Oncol. 2023 Oct 29. doi: 10.1245/s10434-023-14380.
    PubMed    


  106. SONAL S, Berger DL
    ASO Author Reflections: Socio-demographic Disparities in Locations of Death Due to Colorectal Cancer.
    Ann Surg Oncol. 2023 Oct 23. doi: 10.1245/s10434-023-14428.
    PubMed    


  107. TRAN CG, Goffredo P, Mott SL, Suraju MO, et al
    Conditional Overall Survival After Diagnosis of Non-Metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status.
    Ann Surg Oncol. 2023 Oct 19. doi: 10.1245/s10434-023-14443.
    PubMed     Abstract available


  108. ZHENG X, Ye L
    ASO Author Reflections: The Impact of Tumor Deposits on Survival of Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2023 Oct 15. doi: 10.1245/s10434-023-14399.
    PubMed    


  109. HAKKI L, Khan A, Gonen M, Stadler Z, et al
    ASO Visual Abstract: Lymph Node Metastases and Associated Recurrence-Free Survival in Microsatellite Stable and Unstable Colon Cancer.
    Ann Surg Oncol. 2023 Oct 3. doi: 10.1245/s10434-023-14384.
    PubMed    


  110. ZHENG X, Cen W, Zhu J, Ye L, et al
    Prognostic Value of Tumor Deposits in Stage III Colorectal Cancer Patients with Different N Stages: A Population-Based, Retrospective, Cohort Study.
    Ann Surg Oncol. 2023 Oct 2. doi: 10.1245/s10434-023-14338.
    PubMed     Abstract available


  111. KARAGKOUNIS G, McIntyre SM, Wang T, Chou JF, et al
    ASO Visual Abstract: Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A per-Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Ann Surg Oncol. 2023;30:6579-6580.
    PubMed    


  112. SHIMURA Y, Komatsu S, Minami H, Fukumoto T, et al
    ASO Author Reflections: Can the Total Tumor Volume be an Indicator for Optimal Treatment Strategy in Patients with Colorectal Liver Metastases?
    Ann Surg Oncol. 2023;30:6611-6612.
    PubMed    


  113. SHIMURA Y, Komatsu S, Nagatani Y, Funakoshi Y, et al
    ASO Visual Abstract: The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:6613-6614.
    PubMed    


  114. SHIMURA Y, Komatsu S, Nagatani Y, Funakoshi Y, et al
    The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:6603-6610.
    PubMed     Abstract available


  115. KARAGKOUNIS G, McIntyre SM, Wang T, Chou JF, et al
    Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Ann Surg Oncol. 2023;30:6571-6578.
    PubMed     Abstract available


  116. PHAM H, Dixon E
    Integration of Next-Generation Sequencing in the Surgical Management of Colorectal Liver Metastasis.
    Ann Surg Oncol. 2023;30:6815-6823.
    PubMed     Abstract available


    September 2023
  117. KHAN A, Hakki L, Weiser MR
    ASO Author Reflections: Microsatellite Unstable Colon Cancer, Lymph Node Metastases, and Risk of Recurrence.
    Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14359.
    PubMed    


  118. HAKKI L, Khan A, Gonen M, Stadler Z, et al
    Lymph Node Metastases and Associated Recurrence-Free Survival in Microsatellite Stable and Unstable Colon Cancer.
    Ann Surg Oncol. 2023 Sep 12. doi: 10.1245/s10434-023-14270.
    PubMed     Abstract available


  119. KUNITOMO A, Ouchi A
    ASO Author Reflections: Localized Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer-Are They Candidates for Radical Resection?
    Ann Surg Oncol. 2023 Sep 5. doi: 10.1245/s10434-023-14264.
    PubMed    


  120. ZMUC J, Heil J, Herfarth C, Bechstein WO, et al
    ASO Visual Abstract: Chemo- and Targeted Therapy Strategies in Patients with Un- or Borderline Resectable Metastatic Colorectal Cancer-Evidence for a Lack of Focus on Resection Rates.
    Ann Surg Oncol. 2023 Sep 4. doi: 10.1245/s10434-023-14224.
    PubMed    


  121. LIU M, Wei AC
    Colorectal Liver Metastases: Exploring the Extent of Agreement.
    Ann Surg Oncol. 2023;30:5316-5317.
    PubMed    


  122. SLUCKIN TC, Hazen SJA, Horsthuis K, Beets-Tan RGH, et al
    ASO Visual Abstract: Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting.
    Ann Surg Oncol. 2023;30:5486-5488.
    PubMed    


  123. MAKI H, Ayabe RI, Nishioka Y, Konishi T, et al
    ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.
    Ann Surg Oncol. 2023;30:5403-5404.
    PubMed    


  124. SLUCKIN TC, Hazen SJA, Horsthuis K, Beets-Tan RGH, et al
    Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting.
    Ann Surg Oncol. 2023;30:5472-5485.
    PubMed     Abstract available


  125. MAKI H, Ayabe RI, Nishioka Y, Konishi T, et al
    ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer.
    Ann Surg Oncol. 2023;30:5401-5402.
    PubMed    


  126. FROMER MW, Scoggins CR, Egger ME, Philips P, et al
    Reply to: "Current Challenges in Defining Futile Liver Resection and Predicting Early Recurrence After Curative-Intent Treatment for Colorectal Liver Metastases", by Wong, Geoffrey Yuet Mun et al.
    Ann Surg Oncol. 2023;30:5461-5462.
    PubMed    


  127. MAKI H, Ayabe RI, Nishioka Y, Konishi T, et al
    Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.
    Ann Surg Oncol. 2023;30:5390-5400.
    PubMed     Abstract available


  128. KALADY MF, Steele SR
    Top Colorectal Articles from 2021 to Inform Your Cancer Practice.
    Ann Surg Oncol. 2023;30:5489-5494.
    PubMed     Abstract available


  129. KONISHI T
    Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting: Time to Collaborate for Universal Consensus and Training Programs.
    Ann Surg Oncol. 2023;30:5320-5322.
    PubMed    


  130. KUNITOMO A, Ouchi A, Komori K, Kinoshita T, et al
    Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14191.
    PubMed     Abstract available


    August 2023
  131. ZMUC J, Heil J, Herfarth C, Bechstein WO, et al
    Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates.
    Ann Surg Oncol. 2023 Aug 30. doi: 10.1245/s10434-023-14049.
    PubMed     Abstract available


  132. YANG S, Jang H, Park IK, Lee HS, et al
    ASO Visual Abstract: Machine Learning Algorithms Using Systemic Inflammatory Markers for Predicting the Oncological Outcomes of Colorectal Cancer After Surgery.
    Ann Surg Oncol. 2023 Aug 29. doi: 10.1245/s10434-023-14234.
    PubMed    


  133. KHALED C, El Asmar A, Liberale G
    Authors' Response to the Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".
    Ann Surg Oncol. 2023 Aug 24. doi: 10.1245/s10434-023-14196.
    PubMed    


  134. WU H, Wang S, Lv H, Lou F, et al
    Effect of Thoracic Epidural Anesthesia on Perioperative Neutrophil Extracellular Trapping Markers in Patients Undergoing Anesthesia and Surgery for Colorectal Cancer: A Randomized, Controlled Trial.
    Ann Surg Oncol. 2023 Aug 22. doi: 10.1245/s10434-023-14077.
    PubMed     Abstract available


  135. YANG S, Jang H, Park IK, Lee HS, et al
    Machine-Learning Algorithms Using Systemic Inflammatory Markers to Predict the Oncologic Outcomes of Colorectal Cancer After Surgery.
    Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-14136.
    PubMed     Abstract available


  136. YU J, Bai Y, Jin L, Zhang Z, et al
    A Prospective Long-Term Follow-Up Study: The Application of Circulating Tumor Cells Analysis to Guide Adjuvant Therapy in Stage II Colorectal Cancer.
    Ann Surg Oncol. 2023 Aug 19. doi: 10.1245/s10434-023-14168.
    PubMed     Abstract available


  137. ZWART K, van der Baan FH, Punt CJA, Wensink GE, et al
    ASO Visual Abstract: Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
    Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14118.
    PubMed    


  138. KANG J
    ASO Author Reflections: Could the Application of Machine Learning Enhance the Accuracy of Prognosis Estimation Using Serum Inflammatory Markers in Colorectal Cancer Patients?
    Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14154.
    PubMed    


  139. WU H, Wang S, Lv H, Lou F, et al
    ASO Author Reflections: Can Anesthesia Techniques Affect Neutrophil Extracellular Trapping Expression in Patients during Colorectal Cancer Surgery?
    Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14150.
    PubMed    


  140. ZWART K, Roodhart J
    ASO Author Reflections: Clinical Outcome After Upfront Curative-Intent Local Treatment of Metastases in Patient with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2023 Aug 10. doi: 10.1245/s10434-023-14069.
    PubMed    


  141. GIANNONE F, Grollemund A, Schuster C, Pessaux P, et al
    ASO Author Reflections: Oncological Safety of Radiofrequency Ablation in Colorectal Metastases.
    Ann Surg Oncol. 2023;30:4867-4868.
    PubMed    


  142. HILL AL, Cullinan DR, Ahmed O, Vachharajani N, et al
    ASO Visual Abstract: Liver Transplant After Hepatic Artery Infusion Pump Therapy: Single-Center Experience and Technical Considerations.
    Ann Surg Oncol. 2023;30:4781-4782.
    PubMed    


  143. SHARON CE, Wang M, Tortorello GN, Perry NJ, et al
    ASO Visual Abstract: Impact of Patient Comorbidities on Presentation Stage of Breast and Colon Cancers.
    Ann Surg Oncol. 2023;30:4629-4630.
    PubMed    


  144. AL-SUKHNI E, Shapiro J, Suraweera H, Semotiuk K, et al
    Desmoid Tumors in Familial Adenomatous Polyposis Patients: Favorable Outcomes with Multidisciplinary Management.
    Ann Surg Oncol. 2023;30:5142-5149.
    PubMed     Abstract available


  145. WANG XY, Chen JH
    ASO Author Refections: Early ctDNA Dynamics Outperform Conventional Tumor Markers in Predicting Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:5264-5265.
    PubMed    


  146. LIU W, Jin KM, Zhang MH, Bao Q, et al
    Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study.
    Ann Surg Oncol. 2023;30:4916-4926.
    PubMed     Abstract available


  147. WANG XY, Zhang R, Han JH, Chen SQ, et al
    ASO Visual Abstract: Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases-A Prospective Study.
    Ann Surg Oncol. 2023;30:5266.
    PubMed    


  148. KARIM A, Freeman MJ, Yang Q, Leverson G, et al
    ASO Visual Abstract: Duration of Time CD4/CD8 Ratio is Below 0.5 is Associated with Progression to Anal Cancer in Patients with HIV and High-Grade Dysplasia.
    Ann Surg Oncol. 2023;30:4746-4747.
    PubMed    


  149. SHARON CE, Wang M, Tortorello GN, Perry NJ, et al
    Impact of Patient Comorbidities on Presentation Stage of Breast and Colon Cancers.
    Ann Surg Oncol. 2023;30:4617-4626.
    PubMed     Abstract available


  150. WANG XY, Zhang R, Han JH, Chen SQ, et al
    Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases: A Prospective Study.
    Ann Surg Oncol. 2023;30:5252-5263.
    PubMed     Abstract available


  151. GIANNONE F, Grollemund A, Felli E, Mayer T, et al
    ASO Visual Abstract: Combining Radiofrequency Ablation with Hepatic Resection for Liver-Only Colo-rectal Metastases: A Propensity-Score-Based Analysis on Long-Term Outcomes.
    Ann Surg Oncol. 2023;30:4869-4870.
    PubMed    


  152. GIANNONE F, Grollemund A, Felli E, Mayer T, et al
    Combining Radiofrequency Ablation with Hepatic Resection for Liver-Only Colorectal Metastases: A Propensity-Score Based Analysis of Long-Term Outcomes.
    Ann Surg Oncol. 2023;30:4856-4866.
    PubMed     Abstract available


  153. HODGES N, Battersby N, Rao S, Brown G, et al
    ASO Visual Abstract: The Relationship Between Baseline Rectal Tumour Length and Magnetic Resonance Tumour Regression Grade (mrTRG) Response to Chemoradiotherapy-A Sub-analysis of the Trigger Feasibility Study.
    Ann Surg Oncol. 2023;30:4736.
    PubMed    


  154. SHARON CE, Miura JT, Karakousis GC
    ASO Author Reflections: Evaluating the Relationship Between Patient Comorbidities and Stage at Diagnosis for Breast and Colon Cancers.
    Ann Surg Oncol. 2023;30:4627-4628.
    PubMed    


  155. PEREZ RO, Sao Juliao GP
    Rectal Cancer Management and the Long List of Unanswered Questions.
    Ann Surg Oncol. 2023;30:4566-4567.
    PubMed    


  156. YAMAGUCHI T, Akiyoshi T, Fukunaga Y, Sakamoto T, et al
    ASO Visual Abstract: Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncological Outco
    Ann Surg Oncol. 2023;30:4727-4728.
    PubMed    


  157. YAMAGUCHI T, Akiyoshi T, Konishi T
    ASO Author Reflections: Oncological Outcomes of Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2023;30:4725-4726.
    PubMed    


  158. YAMAGUCHI T, Akiyoshi T, Fukunaga Y, Sakamoto T, et al
    Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Scor
    Ann Surg Oncol. 2023;30:4716-4724.
    PubMed     Abstract available


  159. SANGER CB, Striker R
    ASO Author Reflections: Using Objective Markers to Tailor Frequency of Anal Dysplasia Treatments in People Living with HIV.
    Ann Surg Oncol. 2023;30:4744-4745.
    PubMed    


  160. KARIM A, Freeman MJ, Yang Q, Leverson G, et al
    Duration of Time CD4/CD8 Ratio is Below 0.5 is Associated with Progression to Anal Cancer in Patients with HIV and High-Grade Dysplasia.
    Ann Surg Oncol. 2023;30:4737-4743.
    PubMed     Abstract available


  161. HODGES N, Battersby N, Rao S, Brown G, et al
    Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.
    Ann Surg Oncol. 2023;30:4729-4735.
    PubMed     Abstract available


  162. ZWART K, van der Baan FH, Punt CJA, Wensink GE, et al
    Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
    Ann Surg Oncol. 2023 Aug 1. doi: 10.1245/s10434-023-13974.
    PubMed     Abstract available


    July 2023
  163. HAKKI L, Khan A, Ehrich F, Thompson HM, et al
    ASO Visual Abstract: Younger Patients with Colon Cancer are More Likely to Experience Financial Toxicity Than Older Patients.
    Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-14018.
    PubMed    


  164. HAKKI L, Khan A, Ehrich F, Thompson HM, et al
    Younger Patients with Colon Cancer are More Likely to Experience Financial Toxicity Than Older Patients.
    Ann Surg Oncol. 2023 Jul 21. doi: 10.1245/s10434-023-13911.
    PubMed     Abstract available


  165. SUMIYOSHI S, Shiozaki A, Kosuga T, Simizu H, et al
    ASO Visual Abstract: Functional Analysis and Clinical Importance of ATP1A1 in Colon Cancer.
    Ann Surg Oncol. 2023 Jul 20. doi: 10.1245/s10434-023-13915.
    PubMed    


  166. RINER AN, Sharp SP
    ASO Author Reflections: Identifying Racial Disparities for Minimally Invasive Approaches to the Surgical Treatment of Colorectal Cancer.
    Ann Surg Oncol. 2023 Jul 15. doi: 10.1245/s10434-023-13742.
    PubMed    


  167. ZOU M, Li PH, Yang ZQ, Gao F, et al
    Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".
    Ann Surg Oncol. 2023 Jul 15. doi: 10.1245/s10434-023-13917.
    PubMed    


  168. RINER AN, Herremans KM, Deng X, Bandyopadhyay D, et al
    ASO Visual Abstract: Racial/Ethnic Disparities in the Era of Minimally Invasive Surgery for Treatment of Colorectal Cancer.
    Ann Surg Oncol. 2023 Jul 15. doi: 10.1245/s10434-023-13828.
    PubMed    


  169. RINER AN, Herremans KM, Deng X, Bandyopadhyay D, et al
    Racial/Ethnic Disparities in the Era of Minimally Invasive Surgery for Treatment of Colorectal Cancer.
    Ann Surg Oncol. 2023 Jul 9. doi: 10.1245/s10434-023-13693.
    PubMed     Abstract available


  170. SUMIYOSHI S, Shiozaki A, Kosuga T, Simizu H, et al
    Functional Analysis and Clinical Importance of ATP1A1 in Colon Cancer.
    Ann Surg Oncol. 2023 Jul 5. doi: 10.1245/s10434-023-13779.
    PubMed     Abstract available


  171. HAMED AB, Shuai Y, Derby J, Holtzman MP, et al
    ASO Visual Abstract: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4473-4474.
    PubMed    


  172. THOMPSON HM, Widmar M
    ASO Author Reflections: Understanding the Association between Extramural Venous Invasion and Survival in Rectal Cancer Patients.
    Ann Surg Oncol. 2023;30:3966.
    PubMed    


  173. HIYOSHI Y, Daitoku N, Mukai T, Nagasaki T, et al
    ASO Visual Abstract: Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and its Prognostic Impact-A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
    Ann Surg Oncol. 2023;30:3956.
    PubMed    


  174. HAMED AB, Choudry MH
    ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2023;30:4471-4472.
    PubMed    


  175. THOMPSON HM, Bates DDB, Pernicka JG, Park SJ, et al
    ASO Visual Abstract: MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and its Association with Disease-Free and Overall Survival.
    Ann Surg Oncol. 2023;30:3967-3968.
    PubMed    


  176. HAMED AB, Shuai Y, Derby J, Holtzman MP, et al
    Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4459-4470.
    PubMed     Abstract available


  177. MCKIGNEY NA, Houston F, Ross E, Velikova G, et al
    ASO Author Reflections: What is the Quality of Reporting Patient-Reported Outcome Measures in Locally Recurrent Rectal Cancer?
    Ann Surg Oncol. 2023;30:3987-3988.
    PubMed    


  178. MCKIGNEY N, Houston F, Ross E, Velikova G, et al
    Systematic Review of Patient-Reported Outcome Measures in Locally Recurrent Rectal Cancer.
    Ann Surg Oncol. 2023;30:3969-3986.
    PubMed     Abstract available


  179. SOLSKY I, Moaven O, Valenzuela CD, Lundy M, et al
    ASO Visual Abstract: Survival Outcomes of Optimally Treated Colorectal Metastases-The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
    Ann Surg Oncol. 2023;30:4274-4275.
    PubMed    


  180. THOMPSON HM, Bates DDB, Pernicka JG, Park SJ, et al
    MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival.
    Ann Surg Oncol. 2023;30:3957-3965.
    PubMed     Abstract available


  181. HIYOSHI Y, Daitoku N, Mukai T, Nagasaki T, et al
    Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
    Ann Surg Oncol. 2023;30:3944-3953.
    PubMed     Abstract available


  182. SWARTJES H, van Rees JM, van Erning FN, Verheij M, et al
    ASO Visual Abstract: Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective, Cohort Study.
    Ann Surg Oncol. 2023;30:3927-3928.
    PubMed    


  183. HIYOSHI Y, Mukai T, Nagasaki T, Yamaguchi T, et al
    ASO Author Reflections: Rectal Neuroendocrine Tumors Have Strong Potential for Lymph Node Metastasis in Accordance with an Increase of Risk Factors, and Lymph Node Metastasis is Associated with a Poor Prognosis.
    Ann Surg Oncol. 2023;30:3954-3955.
    PubMed    


  184. SCHELL F, Kefleyesus A, Benzerdjeb N, Passot G, et al
    ASO Visual Abstract: Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4457-4458.
    PubMed    


  185. SCHELL F, Kefleyesus A, Benzerdjeb N, Passot G, et al
    Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4444-4454.
    PubMed     Abstract available


  186. SWARTJES H, van Rees JM, van Erning FN, Verheij M, et al
    Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
    Ann Surg Oncol. 2023;30:3915-3924.
    PubMed     Abstract available


  187. SWARTJES H, Koeter T
    ASO Author Reflections: Locally Recurrent Rectal Cancer from a Nationwide Perspective.
    Ann Surg Oncol. 2023;30:3925-3926.
    PubMed    


  188. SOLSKY I, Moaven O, Valenzuela CD, Lundy M, et al
    Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
    Ann Surg Oncol. 2023;30:4264-4273.
    PubMed     Abstract available


    June 2023
  189. SUMIYOSHI S, Shiozaki A, Otsuji E
    ASO Author Reflections: Expression and Role of ATP1A1 in Colon Cancer.
    Ann Surg Oncol. 2023 Jun 21. doi: 10.1245/s10434-023-13790.
    PubMed    


  190. JAIN B, Bajaj SS, Patel TA, Vapiwala N, et al
    ASO Visual Abstract: Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups.
    Ann Surg Oncol. 2023 Jun 17. doi: 10.1245/s10434-023-13699.
    PubMed    


  191. GINESI MC, Bliggenstorfer JT, Kwesiga DM, Xu SH, et al
    ASO Visual Abstract: Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer.
    Ann Surg Oncol. 2023 Jun 16. doi: 10.1245/s10434-023-13705.
    PubMed    


  192. TAGERMAN DL, In H
    ASO Author Reflections: Potentially Avoidable and Prolonged Hospitalizations for Suspected Colon Cancer-Hospital Impact.
    Ann Surg Oncol. 2023 Jun 3. doi: 10.1245/s10434-023-13648.
    PubMed    


  193. SHINTO E, Oki E, Shimokawa M, Yamaguchi S, et al
    ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients.
    Ann Surg Oncol. 2023 Jun 2. doi: 10.1245/s10434-023-13684.
    PubMed    


  194. HARPAIN F, Dawoud C, Wimmer K, Schlager L, et al
    ASO Visual Abstract: Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Ann Surg Oncol. 2023;30:3528-3529.
    PubMed    


  195. CONCORS S, Haddad A, Vauthey JN
    Modeling the Prediction of Early Treatment Failure After Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3182-3183.
    PubMed    


  196. VALENZUELA CD, Moaven O, Solsky IB, Stauffer JA, et al
    ASO Visual Abstract: Conditional Survival After Hepatectomy for Colorectal Liver Metastasis-Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    Ann Surg Oncol. 2023;30:3423-3424.
    PubMed    


  197. DUMONT F, Kepenekian V, De Franco V, Eveno C, et al
    Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study.
    Ann Surg Oncol. 2023;30:3549-3559.
    PubMed     Abstract available


  198. EL ASMAR A, Demetter P, Fares F, Sclafani F, et al
    ASO Visual Abstract: The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases-A Pilot Study.
    Ann Surg Oncol. 2023;30:3331-3332.
    PubMed    


  199. VALENZUELA CD, Moaven O, Solsky IB, Stauffer JA, et al
    Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    Ann Surg Oncol. 2023;30:3413-3422.
    PubMed     Abstract available


  200. RIVARD SJ, Vitous CA, Bamdad MC, Lussiez A, et al
    "I Wish There had been Resources": A Photo-Elicitation Study of Rectal Cancer Survivorship Care Needs.
    Ann Surg Oncol. 2023;30:3530-3537.
    PubMed     Abstract available


  201. KAWAGUCHI Y, Jain AJ, Chun YS, Vauthey JN, et al
    Artificial Intelligence or Tumor Biology to Predict Survival After Resection of Colorectal Liver Metastases?
    Ann Surg Oncol. 2023;30:3161-3162.
    PubMed    


  202. HARPAIN F, Dawoud C, Wimmer K, Schlager L, et al
    Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Ann Surg Oncol. 2023;30:3517-3527.
    PubMed     Abstract available


  203. EL ASMAR A, Demetter P, Fares F, Sclafani F, et al
    The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.
    Ann Surg Oncol. 2023;30:3320-3328.
    PubMed     Abstract available


  204. EL ASMAR A, Liberale G
    ASO Author Reflections: Peritoneal Metastases of Colorectal Origin Exhibit Distinct Histological Growth Patterns with a Potential Prognostic Value.
    Ann Surg Oncol. 2023;30:3329-3330.
    PubMed    


  205. NAKANISHI R, Morooka K, Omori K, Toyota S, et al
    ASO Visual Abstract: Artificial Intelligence-Based Prediction of Recurrence After Curative Resection for Colorectal Cancer From a Digital Pathologic Image.
    Ann Surg Oncol. 2023;30:3515-3516.
    PubMed    


  206. WONG GYM, Diakos C, Molloy MP, Hugh TJ, et al
    Current Challenges in Defining Futile Liver Resection and Predicting Early Recurrence After Curative-Intent Treatment for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3425-3426.
    PubMed    


    May 2023
  207. BOND MJG, Kuiper BI, Bolhuis K, Komurcu A, et al
    ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases-Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
    Ann Surg Oncol. 2023 May 30. doi: 10.1245/s10434-023-13595.
    PubMed    


  208. GINESI MC, Bliggenstorfer JT, Kwesiga DM, Xu SH, et al
    Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer.
    Ann Surg Oncol. 2023 May 30. doi: 10.1245/s10434-023-13631.
    PubMed     Abstract available


  209. YAMAMOTO T, Tsunedomi R, Nakajima M, Suzuki N, et al
    IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2023 May 24. doi: 10.1245/s10434-023-13527.
    PubMed     Abstract available


  210. TAGERMAN DL, Ramos-Santillan V, Kalam A, Wang F, et al
    Potentially Avoidable Admissions and Prolonged Hospitalization in Patients with Suspected Colon Cancer.
    Ann Surg Oncol. 2023 May 17. doi: 10.1245/s10434-023-13593.
    PubMed     Abstract available


  211. YAMAMOTO T, Tsunedomi R, Nakajima M, Suzuki N, et al
    ASO Visual Abstract: Interleukin-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2023 May 17. doi: 10.1245/s10434-023-13644.
    PubMed    


  212. SHINTO E, Oki E, Shimokawa M, Yamaguchi S, et al
    Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients.
    Ann Surg Oncol. 2023 May 8. doi: 10.1245/s10434-023-13594.
    PubMed     Abstract available


  213. YAMAMOTO T, Tsunedomi R, Nakajima M, Nagano H, et al
    ASO Author Reflections: Characteristics of the Relationship Between IL-6 Levels and Tumor Microenvironment in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2023 May 5. doi: 10.1245/s10434-023-13578.
    PubMed    


  214. PROCOPIO F, Branciforte B, Torzilli G
    ASO Author Reflections: Moving Toward the Future: Minimal Access R1 Vascular Surgery for Colorectal Liver Metastases at the Caval Confluence.
    Ann Surg Oncol. 2023;30:2837-2838.
    PubMed    


  215. SASAKI K, Ruffolo LI, Kim MH, Fujiki M, et al
    ASO Visual Abstract: The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting.
    Ann Surg Oncol. 2023;30:2780-2781.
    PubMed    


  216. DOKMAK S, Lesurtel M
    ASO Author Reflections: Surgical Strategy for Bilobar Colorectal Liver Metastases with Vascular Invasion.
    Ann Surg Oncol. 2023;30:2841-2842.
    PubMed    


  217. BERARDI G, Chou J, Gonen M, Balachandran VP, et al
    ASO Visual Abstract: A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:2830-2831.
    PubMed    


  218. BAKKERS C, Rovers KP, Rijken A, Simkens GAAM, et al
    Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.
    Ann Surg Oncol. 2023;30:2678-2688.
    PubMed     Abstract available


  219. KANNO H, Hisaka T, Fujiyoshi K, Akiba J, et al
    ASO Visual Abstract: Prognostic Significance of the Histopathologic Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3149.
    PubMed    


  220. ZINGG SW, Shah SA
    Where are We with Liver Transplant for Unresectable Colorectal Metastases? Its Early, but Some Initial Insights are Evident.
    Ann Surg Oncol. 2023;30:2584-2585.
    PubMed    


  221. SASAKI K, Ruffolo LI, Kim MH, Fujiki M, et al
    The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting.
    Ann Surg Oncol. 2023;30:2769-2777.
    PubMed     Abstract available


  222. BOZHILOV K, Melcher ML, Hernandez-Alejandro R, Sasaki K, et al
    ASO Author Reflections: At the Crossroad-Liver Transplantation for Unresectable Colorectal Liver Metastases in the United States.
    Ann Surg Oncol. 2023;30:2778-2779.
    PubMed    


  223. PROCOPIO F, Cimino M, Milana F, Franchi E, et al
    Laparoscopic Ultrasound-Guided R1 Vascular Liver Resection for Colorectal Liver Metastases at Caval Confluence.
    Ann Surg Oncol. 2023;30:2836.
    PubMed     Abstract available


  224. BERARDI G, D'Angelica M
    ASO Author Reflections: Upfront Surgery for Resectable Colorectal Liver Metastases: Biology is (Still) King.
    Ann Surg Oncol. 2023;30:2828-2829.
    PubMed    


  225. BERARDI G, Chou J, Gonen M, Balachandran VP, et al
    A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:2820-2827.
    PubMed     Abstract available


  226. GRAVERSEN M, Detlefsen S, Ainsworth AP, Fristrup CW, et al
    Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
    Ann Surg Oncol. 2023;30:2634-2644.
    PubMed     Abstract available


  227. GEVA R, Alon G, Nathanson M, Bar-David S, et al
    PD-1 Blockade Combined with Heated Intraperitoneal Chemotherapy Improves Outcome in Experimental Peritoneal Metastases from Colonic Origin in a Murine Model.
    Ann Surg Oncol. 2023;30:2657-2663.
    PubMed     Abstract available


  228. KANNO H, Hisaka T
    ASO Author Reflections: A Combination of the Histopathologic Growth Pattern and Tumor-Infiltrating Lymphocytes Can Stratify the Risk in Survival After Hepatectomy for Colorectal Liver Metastasis.
    Ann Surg Oncol. 2023;30:3148.
    PubMed    


  229. KANNO H, Hisaka T, Fujiyoshi K, Akiba J, et al
    Prognostic Significance of the Histopathological Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3139-3147.
    PubMed     Abstract available


  230. JASTRZEBSKI T
    Unreliability in the Treatment of Patients with Peritoneal Metastases of Colorectal Cancer in the Current NCCN and ASCO Recommendations.
    Ann Surg Oncol. 2023 May 1. doi: 10.1245/s10434-023-13576.
    PubMed    


    April 2023
  231. JAIN B, Bajaj SS, Patel TA, Vapiwala N, et al
    ASO Author Reflections: Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders.
    Ann Surg Oncol. 2023 Apr 29. doi: 10.1245/s10434-023-13560.
    PubMed    


  232. BOND MJG, Kuiper BI, Bolhuis K, Komurcu A, et al
    Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
    Ann Surg Oncol. 2023 Apr 28. doi: 10.1245/s10434-023-13510.
    PubMed     Abstract available


  233. BOND MJG, Punt CJA, Swijnenburg RJ
    ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2023 Apr 21. doi: 10.1245/s10434-023-13513.
    PubMed    


  234. CHILDERS CP, Uppal A, Tillman M, Chang GJ, et al
    ASO Visual Abstract: Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2023 Apr 13. doi: 10.1245/s10434-023-13454.
    PubMed    


  235. KOZMAN MA, Fisher OM, Liauw W, Morris DL, et al
    Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians.
    Ann Surg Oncol. 2023 Apr 5. doi: 10.1245/s10434-022-12794.
    PubMed     Abstract available


  236. JAIN B, Bajaj SS, Patel TA, Vapiwala N, et al
    Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups.
    Ann Surg Oncol. 2023 Apr 5:1-11. doi: 10.1245/s10434-023-13339.
    PubMed     Abstract available


  237. WEI AC
    Practice-Changing Evidence in Surgical Oncology 2021: Hepatobiliary Articles.
    Ann Surg Oncol. 2023;30:1960-1965.
    PubMed     Abstract available


  238. DIETZ MV, Ziekman MJ, van Kooten JP, Brandt-Kerkhof ARM, et al
    ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Ann Surg Oncol. 2023;30:2057.
    PubMed    


  239. NIKIFORCHIN A, Sardi A, King MC, Baron E, et al
    ASO Visual Abstract: Safety of Nephrectomy Performed During CRS/HIPEC-A Propensity Score-Matched Study.
    Ann Surg Oncol. 2023;30:2531.
    PubMed    


  240. DIETZ MV, Ziekman MJ, van Kooten JP, Brandt-Kerkhof ARM, et al
    Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Ann Surg Oncol. 2023;30:2048-2056.
    PubMed     Abstract available


  241. MANGIERI CW, Valenzuela CD, Solsky IB, Erali RA, et al
    Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Ann Surg Oncol. 2023;30:2486-2493.
    PubMed     Abstract available


    March 2023
  242. HONAKER MD, Irish W, Parikh AA, Snyder RA, et al
    ASO Author Reflections: Rural-Urban Disparities in Colon Cancer Care: Trying to Close the Gap.
    Ann Surg Oncol. 2023 Mar 31. doi: 10.1245/s10434-023-13381.
    PubMed    


  243. KOZMAN MA, Fisher OM, Liauw W, Morris DL, et al
    ASO Visual Abstract: Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncol
    Ann Surg Oncol. 2023 Mar 30. doi: 10.1245/s10434-022-12857.
    PubMed    


  244. HONAKER MD, Irish W, Parikh AA, Snyder RA, et al
    ASO Visual Abstract: Association of Rural Residence and Receipt of Guideline Concordant Care for Locoregional Colon Cancer.
    Ann Surg Oncol. 2023 Mar 30. doi: 10.1245/s10434-023-13403.
    PubMed    


  245. CHILDERS CP, Uppal A, Tillman M, Chang GJ, et al
    Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2023 Mar 21. doi: 10.1245/s10434-023-13354.
    PubMed     Abstract available


  246. HONAKER MD, Irish W, Parikh AA, Snyder RA, et al
    Association of Rural Residence and Receipt of Guideline-Concordant Care for Locoregional Colon Cancer.
    Ann Surg Oncol. 2023 Mar 18. doi: 10.1245/s10434-023-13340.
    PubMed     Abstract available


  247. VALLEJOS PA, Gonda A, Yu J, Sullivan BG, et al
    ASO Visual Abstract: Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.
    Ann Surg Oncol. 2023 Mar 16. doi: 10.1245/s10434-023-13303.
    PubMed    


  248. KEPENEKIAN V, Kefleyesus A, Passot G, Rousset P, et al
    ASO Author Reflections: Colorectal Cancer Patients with Peritoneal Metastases and Other Metastatic Sites Can Benefit from Radical Multifocal Treatment After Comprehensive Evaluation for Accurate Selection.
    Ann Surg Oncol. 2023 Mar 12. doi: 10.1245/s10434-023-13320.
    PubMed    


  249. FANGET F, Kefleyesus A, Peron J, Bonnefoy I, et al
    ASO Visual Abstract: Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes - A Retr
    Ann Surg Oncol. 2023 Mar 7. doi: 10.1245/s10434-023-13300.
    PubMed    


  250. VALLEJOS PA, Gonda A, Yu J, Sullivan BG, et al
    Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.
    Ann Surg Oncol. 2023 Mar 2. doi: 10.1245/s10434-023-13219.
    PubMed     Abstract available


  251. HANY TS, Jadav AM, Bhowmick AK
    ASO Visual Abstract: The Extra-Peritoneal Approach to Left-Sided Colorectal Rectal Resections-EXPERTS Procedure.
    Ann Surg Oncol. 2023;30:1742-1743.
    PubMed    


  252. HANY TS, Jadav AM, Lamoon C, Cassidy K, et al
    The Extraperitoneal Approach to Left-Sided Colorectal Rectal Resections: EXPERTS Procedure.
    Ann Surg Oncol. 2023;30:1739-1740.
    PubMed     Abstract available


  253. SINNAMON AJ, Luo E, Xu A, Zhu S, et al
    Simultaneous Hepatic and Visceral Resection: Preoperative Risk Stratification and Implications on Return to Intended Oncologic Therapy.
    Ann Surg Oncol. 2023;30:1772-1783.
    PubMed     Abstract available


  254. BEAL EW, Srinivas S, Shen C, Kim A, et al
    Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
    Ann Surg Oncol. 2023;30:1840-1849.
    PubMed     Abstract available


    February 2023
  255. ALON G, Geva R, Lahat G, Nizri E, et al
    ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2023 Feb 17. doi: 10.1245/s10434-023-13254.
    PubMed    


  256. KEPENEKIAN V, Kefleyesus A, Passot G, Rousset P, et al
    ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?
    Ann Surg Oncol. 2023 Feb 8. doi: 10.1245/s10434-023-13214.
    PubMed    


  257. ABDELFATAH E, Ramos-Santillan V, Cherkassky L, Cianchetti K, et al
    ASO Visual Abstract: High Risk, High Reward: Frailty in Colorectal Cancer Surgery Associates with Worse Postoperative Outcomes But Equivalent Long-Term Oncologic Outcomes.
    Ann Surg Oncol. 2023 Feb 6. doi: 10.1245/s10434-022-13090.
    PubMed    


  258. FANGET F, Kefleyesus A, Peron J, Bonnefoy I, et al
    Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study.
    Ann Surg Oncol. 2023 Feb 2. doi: 10.1245/s10434-023-13150.
    PubMed     Abstract available


  259. BHULLAR D, O'Dwyer S, Wilson M, Saunders MP, et al
    ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:802-803.
    PubMed    


  260. BHULLAR D, O'Dwyer S, Wilson M, Saunders MP, et al
    RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:792-801.
    PubMed     Abstract available


  261. CHOI M, Harper MM, Pandalai PK, Abdel-Misih SRZ, et al
    A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease.
    Ann Surg Oncol. 2023;30:804-813.
    PubMed     Abstract available


    January 2023
  262. HANEVELT J, Moons LMG, Hentzen JEKR, Wemeijer TM, et al
    ASO Visual Abstract: Colonoscopy-Assisted Laparoscopic Wedge Resection for the Treatment of Suspected T1 Colon Cancer.
    Ann Surg Oncol. 2023 Jan 21. doi: 10.1245/s10434-022-13070.
    PubMed    


  263. HUANG E, Kalady MF
    45 is the New 50: Demographic Trends in Colorectal Cancer Drive Recent US Screening Guideline Changes.
    Ann Surg Oncol. 2023 Jan 19. doi: 10.1245/s10434-022-12986.
    PubMed    


  264. ABDELFATAH E, Ramos-Santillan V, Cherkassky L, Cianchetti K, et al
    High Risk, High Reward: Frailty in Colorectal Cancer Surgery is Associated with Worse Postoperative Outcomes but Equivalent Long-Term Oncologic Outcomes.
    Ann Surg Oncol. 2023 Jan 17. doi: 10.1245/s10434-022-12970.
    PubMed     Abstract available


  265. JASTRZEBSKI T
    Colorectal Cancer T4: Should Prophylactic HIPEC be Performed? : Colorectal T4 HIPEC Prophylactic.
    Ann Surg Oncol. 2023 Jan 16. doi: 10.1245/s10434-023-13100.
    PubMed    


  266. PEERENBOOM R, Dhiman A, Witmer HDD, Spurr LF, et al
    ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
    Ann Surg Oncol. 2023 Jan 15. doi: 10.1245/s10434-022-12854.
    PubMed    


  267. PEERENBOOM R, Dhiman A, Witmer HDD, Spurr LF, et al
    PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
    Ann Surg Oncol. 2023 Jan 13. doi: 10.1245/s10434-022-12784.
    PubMed     Abstract available


  268. HANEVELT J, Moons LMG, Hentzen JEKR, Wemeijer TM, et al
    Colonoscopy-Assisted Laparoscopic Wedge Resection for the Treatment of Suspected T1 Colon Cancer.
    Ann Surg Oncol. 2023 Jan 4. doi: 10.1245/s10434-022-12973.
    PubMed     Abstract available


  269. HANEVELT J, Moons LMG, de Vos Tot Nederveen Cappel WH, van Westreenen HL, et al
    ASO Author Reflections: Colonoscopic-Assisted Laparoscopic Wedge Resection Seems a Valuable Addition to the Current Local Resection Techniques in Case of Suspected Deep-Invasive T1 Colon Cancer.
    Ann Surg Oncol. 2023 Jan 4. doi: 10.1245/s10434-022-13051.
    PubMed    


  270. RAMSAY R, Sampurno S, Flood MP, Lynch AC, et al
    ASO Author Reflections: Humidification of Carbon Dioxide for Insufflation Offers Promise in Reducing Inflammation and Peritoneal Trauma During and Post Colorectal Cancer Surgery.
    Ann Surg Oncol. 2023 Jan 2. doi: 10.1245/s10434-022-13014.
    PubMed    


  271. KEILSON JM, Gamboa AC, Turgeon MK, Maguire L, et al
    Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?
    Ann Surg Oncol. 2023;30:224-232.
    PubMed     Abstract available


  272. ARSHAD M, Al-Hallaq H, Polite BN, Shogan BD, et al
    Intra-operative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry.
    Ann Surg Oncol. 2023;30:325-332.
    PubMed     Abstract available


  273. ARSHAD M, Al-Hallaq H, Polite BN, Shogan BD, et al
    ASO Visual Abstract: Intraoperative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry.
    Ann Surg Oncol. 2023;30:333-334.
    PubMed    


    December 2022
  274. SWARTJES H, van Lankveld DWP, van Erning FN, Verheul HMW, et al
    ASO Visual Abstract: Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study.
    Ann Surg Oncol. 2022 Dec 19. doi: 10.1245/s10434-022-12782.
    PubMed    


  275. NAKANISHI R, Morooka K, Omori K, Toyota S, et al
    Artificial Intelligence-Based Prediction of Recurrence after Curative Resection for Colorectal Cancer from Digital Pathological Images.
    Ann Surg Oncol. 2022 Dec 13. doi: 10.1245/s10434-022-12926.
    PubMed     Abstract available


  276. NEWTON AD, Newhook TE, Ikoma N, Tzeng CD, et al
    Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:8455.
    PubMed     Abstract available


  277. MACHADO MAC, Mattos BV, Lobo Filho MM, Makdissi F, et al
    ASO Visual Abstract: Glissonian Approach During Robotic Mesohepatectomy for Recurrent Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:8454.
    PubMed    


  278. KAWADA K, Itatani Y, Horie A, Yamanaka H, et al
    Robotic Posterior Exenteration for Locally Advanced Rectal Cancer with Rectovaginal Fistula.
    Ann Surg Oncol. 2022;29:8211-8212.
    PubMed    


  279. MACHADO MAC, Mattos BV, Lobo Filho MM, Makdissi F, et al
    Glissonian Approach During Robotic Mesohepatectomy for Recurrent Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:8449-8451.
    PubMed    


    November 2022
  280. EL ASMAR A, Delcourt M, Kamden L, Khaled C, et al
    ASO Visual Abstract: Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2022 Nov 19. doi: 10.1245/s10434-022-12817.
    PubMed    


  281. EL ASMAR A, Delcourt M, Kamden L, Khaled C, et al
    Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2022 Nov 9. pii: 10.1245/s10434-022-12736.
    PubMed     Abstract available


  282. GRIFFITHS CD, Karanicolas P, Gallinger S, Wei AD, et al
    Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2022 Nov 9. pii: 10.1245/s10434-022-12696.
    PubMed     Abstract available


  283. EL ASMAR A, Liberale G
    ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin.
    Ann Surg Oncol. 2022 Nov 6. pii: 10.1245/s10434-022-12771.
    PubMed    


  284. SWARTJES H, de Wilt H
    ASO Author Reflections: Real-World Conclusions on Locoregionally Recurrent Colon Cancer.
    Ann Surg Oncol. 2022 Nov 5. pii: 10.1245/s10434-022-12772.
    PubMed    


  285. FLOOD MP, Kong JCH, Heriot AG
    Reply to Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis".
    Ann Surg Oncol. 2022;29:7935-7936.
    PubMed    


  286. LIBERALE G, Moreau M, Repullo D
    Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis".
    Ann Surg Oncol. 2022;29:7933-7934.
    PubMed    


  287. NARAYAN RR, Datta J, D'Angelica MI
    ASO Visual Abstract: Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Ann Surg Oncol. 2022;29:7591.
    PubMed    


  288. SONAL S, Deshpande V, Ting DT, Cusack JC, et al
    ASO Visual Abstract: Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma : Tumor Microenvironment in EMVI-Positive Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:7384-7385.
    PubMed    


  289. SONAL S, Berger DL
    ASO Author Reflections: Colorectal Cancers with Extramural Vascular Invasion Are Associated with a Low Immune Microenvironment.
    Ann Surg Oncol. 2022;29:7383.
    PubMed    


  290. SONAL S, Deshpande V, Ting DT, Cusack JC, et al
    Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:7372-7382.
    PubMed     Abstract available


  291. NARAYAN RR, Datta J, Goldman DA, Aveson VG, et al
    Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Ann Surg Oncol. 2022;29:7579-7588.
    PubMed     Abstract available


  292. DELHORME JB, Sauvinet G, Severac F, Diab S, et al
    Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: The Efficiency of Mitomycin C.
    Ann Surg Oncol. 2022;29:7568-7576.
    PubMed     Abstract available


  293. DELHORME JB, Sauvinet G, Severac F, Diab S, et al
    ASO Visual Abstract: Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy-The Efficiency of Mitomycin C.
    Ann Surg Oncol. 2022;29:7577-7578.
    PubMed    


  294. NESGAARD JM, Stimec BV, Ignjatovic D
    Comments on Superior Mesenteric Artery First Approach for Right Colectomy.
    Ann Surg Oncol. 2022;29:7923-7924.
    PubMed    


  295. JUDGE SJ, Cho M, Gholami S
    Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy by Narayan et al.
    Ann Surg Oncol. 2022;29:7246-7247.
    PubMed    


  296. LUO W, Lu T, Xiao Y
    Response to Letter to the Editor: "Comments to Superior Mesenteric Artery First Approach for Right Colectomy" by Jens Marius Nesgaard et al.
    Ann Surg Oncol. 2022;29:7925-7926.
    PubMed    


  297. NARAYAN RR, Datta J, D'Angelica MI
    ASO Author Reflections: Ras-p53 Cooperativity Predicts Recurrence Patterns After Resection of Colorectal Liver Metastases with Adjuvant Local and Systemic Chemotherapy.
    Ann Surg Oncol. 2022;29:7589-7590.
    PubMed    


  298. HEIL TC, Verdaasdonk EGG, Maas HAAM, van Munster BC, et al
    ASO Visual Abstract: Improved Postoperative Outcomes After Prehabilitation for Colorectal Cancer Surgery in Older Patients: An Emulated Target Trial.
    Ann Surg Oncol. 2022 Nov 1. pii: 10.1245/s10434-022-12720.
    PubMed    


  299. DAWOOD ZS, Alaimo L, Lima HA, Moazzam Z, et al
    ASO Visual Abstract: Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies in Patients Who Underwent Resection pf Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022 Nov 1. pii: 10.1245/s10434-022-12728.
    PubMed    


    October 2022
  300. LAMBDIN J, Ryan CE, Alejandro RH, Baker T, et al
    Neoadjuvant Chemotherapy Plus Living Donor Transplantation (LDLT) for Non-Resectable Liver Metastases from Colorectal Cancer (CRC).
    Ann Surg Oncol. 2022 Oct 31. pii: 10.1245/s10434-022-12649.
    PubMed    


  301. DAWOOD ZS, Moazzam Z, Pawlik TM
    ASO Author Reflections: Assessing the Diagnostic Accuracy of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen to Detect Recurrent Colon Cancer.
    Ann Surg Oncol. 2022 Oct 30. pii: 10.1245/s10434-022-12678.
    PubMed    


  302. KEMENY MM, Zhao F, Forastiere AA, Catalano P, et al
    Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
    Ann Surg Oncol. 2022 Oct 28. pii: 10.1245/s10434-022-12705.
    PubMed     Abstract available


  303. SWARTJES H, van Lankveld DWP, van Erning FN, Verheul HMW, et al
    Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study.
    Ann Surg Oncol. 2022 Oct 19. pii: 10.1245/s10434-022-12689.
    PubMed     Abstract available


  304. HEIL TC, Verdaasdonk EGG, Maas HAAM, van Munster BC, et al
    ASO Author Reflections: Real-World Effectiveness of Prehabilitation Before Colorectal Cancer Surgery: The Value of an Emulated Target Trial Design.
    Ann Surg Oncol. 2022 Oct 17. pii: 10.1245/s10434-022-12672.
    PubMed    


  305. ITO K, Osakabe M, Sugimoto R, Yamada S, et al
    Differential Expression in the Tumor Microenvironment of mRNAs Closely Associated with Colorectal Cancer Metastasis.
    Ann Surg Oncol. 2022 Oct 12. pii: 10.1245/s10434-022-12574.
    PubMed     Abstract available


  306. AQUINA CT, Brown ZJ, Beane JD, Ejaz A, et al
    ASO Visual Abstract: Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2022 Oct 11. pii: 10.1245/s10434-022-12652.
    PubMed    


  307. DAWOOD ZS, Alaimo L, Lima HA, Moazzam Z, et al
    Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer-A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2022 Oct 11. pii: 10.1245/s10434-022-12641.
    PubMed     Abstract available


  308. HEIL TC, Verdaasdonk EGG, Maas HAAM, van Munster BC, et al
    Improved Postoperative Outcomes after Prehabilitation for Colorectal Cancer Surgery in Older Patients: An Emulated Target Trial.
    Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12623.
    PubMed     Abstract available


  309. ITO K, Osakabe M, Sugimoto R, Yamada S, et al
    ASO Visual Abstract: Differential Expression in the Tumor Microenvironment of mRNAs Closely Associated with Colorectal Cancer Metastasis.
    Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12629.
    PubMed    


  310. DI MARTINO M, Primavesi F, Syn N, Dorcaratto D, et al
    Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring.
    Ann Surg Oncol. 2022;29:6829-6842.
    PubMed     Abstract available


  311. DI MARTINO M, Primavesi F
    ASO Author Reflections: Peri-operative Chemotherapy for Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:6843-6844.
    PubMed    


  312. DI MARTINO M, Primavesi F, Syn N, Dorcaratto D, et al
    ASO Visual Abstract: Long-Term Outcomes of Perioperative versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases-An International Multicenter Propensity-Score Matched Analysis with Stratification by Contemporary Risk Scoring.
    Ann Surg Oncol. 2022;29:6845-6846.
    PubMed    


  313. HORI Y, Seo S, Yoh T, Ueno K, et al
    Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy.
    Ann Surg Oncol. 2022;29:6745-6754.
    PubMed     Abstract available


  314. HORI Y, Seo S
    ASO Author Reflections: CEA Uptrend is a Useful Biomarker to Predict Post-Hepatectomy Survival Outcomes in Patients with Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:6755-6756.
    PubMed    


  315. DIETZ MV, van Kooten JP, Said I, Brandt-Kerkhof ARM, et al
    Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:6566-6576.
    PubMed     Abstract available


  316. DIETZ MV, Madsen EVE
    ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:6577-6578.
    PubMed    


  317. FLOOD MP, Ramsay R, Michael M, Heriot AG, et al
    ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
    Ann Surg Oncol. 2022;29:6632-6633.
    PubMed    


  318. FLOOD MP, Kong JCH, Wilson K, Mohan H, et al
    The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:6619-6631.
    PubMed     Abstract available


  319. WHITE MG, Badgwell B
    Oncologic Components of HIPEC: Key Question : In patients with gastric or colorectal adenocarcinoma metastatic to the peritoneum, does cytoreductive surgery (CRS) plus hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC) prolong survival o
    Ann Surg Oncol. 2022;29:6561-6564.
    PubMed    


    September 2022
  320. YOSHIKAWA Y, Fukunaga M, Takahashi J, Shimizu D, et al
    Identification of the Minimum Combination of Serum microRNAs to Predict the Recurrence of Colorectal Cancer Cases.
    Ann Surg Oncol. 2022 Sep 29. pii: 10.1245/s10434-022-12355.
    PubMed     Abstract available


  321. AQUINA CT, Brown ZJ, Beane JD, Ejaz A, et al
    Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2022 Sep 23. pii: 10.1245/s10434-022-12513.
    PubMed     Abstract available


  322. PEDRAZZANI C, Turri G, Marrelli D, Kim HJ, et al
    ASO Visual Abstract: Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort.
    Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12473.
    PubMed    


  323. SOULEN MC, White SB
    Another Signal from DEBIRI.
    Ann Surg Oncol. 2022;29:5357-5358.
    PubMed    


  324. VIGANO L, Branciforte B, Laurenti V, Costa G, et al
    The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin.
    Ann Surg Oncol. 2022;29:5515-5524.
    PubMed     Abstract available


  325. DIETZ MV, van Kooten JP, van Vugt JLA, Brandt-Kerkhof ARM, et al
    The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:5830-5841.
    PubMed     Abstract available


  326. LEIGH N, Williams GA, Strasberg SM, Fields RC, et al
    Increased Morbidity and Mortality After Hepatectomy for Colorectal Liver Metastases in Frail Patients is Largely Driven by Worse Outcomes After Minor Hepatectomy: It's Not "Just a Wedge".
    Ann Surg Oncol. 2022;29:5476-5485.
    PubMed     Abstract available


  327. VIGANO L, Branciforte B, Laurenti V, Torzilli G, et al
    ASO Author Reflections: The Histopathological Growth Pattern of Colorectal Liver Metastases: A New Biomarker to Drive Surgical Strategy.
    Ann Surg Oncol. 2022;29:5525-5526.
    PubMed    


  328. PARO A, Hyer JM, Shaikh CF, Pawlik TM, et al
    Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:5387-5397.
    PubMed     Abstract available


  329. PARO A, Pawlik TM
    ASO Author Reflections: The Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:5398-5399.
    PubMed    


    August 2022
  330. PARK EJ, Ahn J, Abuzar SM, Park KS, et al
    Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo.
    Ann Surg Oncol. 2022 Aug 30. pii: 10.1245/s10434-022-12358.
    PubMed     Abstract available


  331. PARK EJ, Ahn J, Abuzar SM, Park KS, et al
    ASO Visual Abstract: Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo.
    Ann Surg Oncol. 2022 Aug 27. pii: 10.1245/s10434-022-12393.
    PubMed    


  332. YOSHINO K, Osumi H, Ito H, Kamiimabeppu D, et al
    ASO Visual Abstract: Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2022 Aug 21. pii: 10.1245/s10434-022-12336.
    PubMed    


  333. YOSHINO K, Osumi H, Ito H, Kamiimabeppu D, et al
    Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2022 Aug 16. pii: 10.1245/s10434-022-12301.
    PubMed     Abstract available


  334. ZOU M, Gui MB, Gao H, Gao F, et al
    Comment on "Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer".
    Ann Surg Oncol. 2022 Aug 13. pii: 10.1245/s10434-022-12376.
    PubMed    


  335. KANG J
    Reply to Letter by Min Zou et al.: Comment on "Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer".
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12377.
    PubMed    


  336. YOSHINO K, Osumi H, Ito H, Yamaguchi K, et al
    ASO Author Reflections: The Role of CEA Optimizing Perioperative Treatments for Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12372.
    PubMed    


  337. KLEMEN ND, Court CM, Fernandes MC, Walch HS, et al
    Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.
    Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12095.
    PubMed     Abstract available


  338. HAGIHARA K, Haraguchi N, Nishimura J, Yasueda A, et al
    PLXND1/SEMA3E Promotes Epithelial-Mesenchymal Transition Partly via the PI3K/AKT-Signaling Pathway and Induces Heterogenity in Colorectal Cancer.
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-11945.
    PubMed     Abstract available


  339. LUO W, Lu T, Xiao Y
    ASO Author Reflections: A New "Superior Mesenteric Artery-First" Approach for Complete Mesocolic Excision with Central Vascular Ligation in Laparoscopic Right Hemicolectomy.
    Ann Surg Oncol. 2022;29:5074-5075.
    PubMed    


  340. COSTANTINI B, Vargiu V, Santullo F, Rosati A, et al
    Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience.
    Ann Surg Oncol. 2022;29:4791-4802.
    PubMed     Abstract available


  341. SAID I, Ubink I, Ewalds RSG, Arkesteijn JGT, et al
    In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival.
    Ann Surg Oncol. 2022;29:5256-5262.
    PubMed     Abstract available


  342. MASON MC, Krasnodebski M, Hester CA, Kothari AN, et al
    Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection.
    Ann Surg Oncol. 2022;29:5156-5164.
    PubMed     Abstract available


  343. TAIBI A, Hubner M, Eveno C, Dumont F, et al
    ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?
    Ann Surg Oncol. 2022;29:5252-5253.
    PubMed    


  344. AIBUEDEFE B, Hamilton KS, Yong V, Kling SM, et al
    It's Not About the Money: Continued Treatment and Survival Outcome Disparities in Minority Rectal Cancer Patients After Controlling for Socioeconomic Factors.
    Ann Surg Oncol. 2022;29:5056-5062.
    PubMed     Abstract available


  345. TAIBI A, Sgarbura O, Hubner M, Bardet SM, et al
    Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
    Ann Surg Oncol. 2022;29:5243-5251.
    PubMed     Abstract available


  346. HAMILTON KS, Aibuedefe B, Yong V, Kling SM, et al
    ASO Author Reflections: Inequities in Rectal Cancer Treatment and Survival.
    Ann Surg Oncol. 2022;29:5063-5064.
    PubMed    


  347. CARBONI F, Valle M
    Letter to Editor of Annals of Surgical Oncology Concerning "Early Diagnosis of Anastomotic Leakage after Gastric Cancer Surgery via Analysis of Inflammatory Factors in Abdominal Drainage".
    Ann Surg Oncol. 2022;29:5107-5108.
    PubMed    


  348. HAGIHARA K, Haraguchi N, Nishimura J, Yasueda A, et al
    ASO Visual Abstract: PLXND1/SEMA3E Promotes EMT Partly via the PI3K/AKT Signaling Pathway and Induces Heterogeneity in Colorectal Cancer.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12111.
    PubMed    


  349. ANGKA L, Martel AB, Ng J, Pecarskie A, et al
    ASO Visual Abstract: A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12281.
    PubMed    


    July 2022
  350. SINGH J, Kannan A, Pant A, Paruthy E, et al
    Effect of Socioeconomic Inequalities on the Surgical Treatment and Outcomes of Patients with Colon Cancer.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12316.
    PubMed    


  351. ANGKA L, Martel AB, Ng J, Pecarskie A, et al
    A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12202.
    PubMed     Abstract available


  352. SAMPURNO S, Chittleborough T, Dean M, Flood M, et al
    ASO Visual Abstract: Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery-A Randomised Controlled Trial.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12241.
    PubMed    


  353. HAWKINS AT
    I've Got Bad News and Bad News: The Cost of Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12172.
    PubMed    


  354. PEDRAZZANI C, Turri G, Choi GS
    ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer.
    Ann Surg Oncol. 2022 Jul 12. pii: 10.1245/s10434-022-12180.
    PubMed    


  355. SAMPURNO S, Chittleborough T, Dean M, Flood M, et al
    Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled Trial.
    Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12057.
    PubMed     Abstract available


  356. PEDRAZZANI C, Turri G, Marrelli D, Kim HJ, et al
    Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort.
    Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12097.
    PubMed     Abstract available


  357. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
    ASO Visual Abstract: Time to Incurable Recurrence for Patients Who Receive Pulmonary Metastasectomy for Colorectal Cancer.
    Ann Surg Oncol. 2022 Jul 4. pii: 10.1245/s10434-022-12073.
    PubMed    


    June 2022
  358. TANG W, Liu Y, Ji M, Liu T, et al
    Correction to: Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases.
    Ann Surg Oncol. 2022 Jun 24. pii: 10.1245/s10434-022-12051.
    PubMed    


  359. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
    Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal Cancer.
    Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-11904.
    PubMed     Abstract available


  360. THEISS LM, Lucy AT, Bergstresser SL, Chu DI, et al
    Disparities in Surgical Timing and Guideline-Adherent Staging Work-Up for Colon Cancer.
    Ann Surg Oncol. 2022 Jun 6. pii: 10.1245/s10434-022-11938.
    PubMed     Abstract available


  361. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:3420-3421.
    PubMed    


  362. ZHU HB, Xu D, Zhang XY, Li XT, et al
    ASO Visual Abstract: Prediction of Therapeutic Effect of Treatment on Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study Comparing Bevacizumab-Containing Chemotherapy and Standard C
    Ann Surg Oncol. 2022;29:3950.
    PubMed    


  363. OMICHI K, Inoue Y, Mise Y, Oba A, et al
    ASO Visual Abstract: Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival.
    Ann Surg Oncol. 2022;29:3577.
    PubMed    


  364. KHIN NY, De Silva M, Clarke S, Pavlakis N, et al
    Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:3387-3389.
    PubMed    


  365. OMICHI K, Inoue Y, Mise Y, Oba A, et al
    Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival.
    Ann Surg Oncol. 2022;29:3567-3576.
    PubMed     Abstract available


  366. ZHU HB, Xu D, Zhang XY, Li XT, et al
    Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemothera
    Ann Surg Oncol. 2022;29:3938-3949.
    PubMed     Abstract available


  367. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2022;29:3405-3417.
    PubMed     Abstract available


  368. TONELLO M, Sommariva A
    ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2022;29:3418-3419.
    PubMed    


    May 2022
  369. DIAZ VICO T, Garcia Florez LJ
    Letter to the Editor Reply: 'Mesocolon Excision in Right Colon Cancer: Is it a Real Oncological Procedure or a Mere Surgical Act?'
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11879.
    PubMed    


  370. GRAZIOSI L, Marino E
    Mesocolon Excision in Right Colon Cancer: Is it a Real Oncological Procedure or a Mere Surgical Act?
    Ann Surg Oncol. 2022 May 5. pii: 10.1245/s10434-022-11872.
    PubMed    


  371. FOSTER JM, Zhang C
    ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.
    Ann Surg Oncol. 2022;29:3347-3348.
    PubMed    


  372. ZHANG C, Patel A, Hegeholz D, Brown K, et al
    Cytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis.
    Ann Surg Oncol. 2022;29:3337-3346.
    PubMed     Abstract available


  373. TEO QT, Koh FH, Ladlad J, Foo FJ, et al
    Laparoscopic Anterior Resection with Anastomosis of Mid-Transverse to Distal Rectum with Deloyers Procedure Under Indocyanine Green fluorescence Guidance: A Video Case Report.
    Ann Surg Oncol. 2022;29:3071.
    PubMed     Abstract available


  374. MATSUDA T, Sawada R, Hasegawa H, Yamashita K, et al
    Standardized Procedure of Transperineal Minimally Invasive Abdominoperineal Resection for Low Rectal Cancer.
    Ann Surg Oncol. 2022;29:3065.
    PubMed     Abstract available


  375. KAMARAJAH SK, Griffiths EA, Phillips AW, Ruurda J, et al
    ASO Visual Abstract: Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes.
    Ann Surg Oncol. 2022;29:2828-2829.
    PubMed    


  376. SUN Y, Yang H, Zhang Z, Zhou Y, et al
    ASO Visual Abstract: Laparoscopic Pelvic Exenteration with Bladder Sparing for Men with Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2022;29:3069-3070.
    PubMed    


  377. MATSUDA T
    ASO Author Reflections: What is the Most Reasonable Approach to Abdominoperineal Resection for Low Rectal Cancer?
    Ann Surg Oncol. 2022;29:3066.
    PubMed    


  378. SUN Y, Yang H, Zhang Z, Zhou Y, et al
    Laparoscopic Pelvic Exenteration with Bladder Sparing for Men with Locally Advanced Rectal Cancer (with Video).
    Ann Surg Oncol. 2022;29:3067-3068.
    PubMed     Abstract available


  379. YAMADA T, Matsuda A, Takahashi G, Yoshida H, et al
    Oncological Risk of Colonic Stents Used as Bridge to Surgery for Left-Side Malignant Colonic Obstructions.
    Ann Surg Oncol. 2022;29:2759-2760.
    PubMed    


    April 2022
  380. LUO W, Cai Z, Li F, Lu T, et al
    Laparoscopic Complete Mesocolic Excision with Central Vascular Ligation (CME + CVL) for Right-Sided Colon Cancer: A New "Superior Mesenteric Artery First" Approach.
    Ann Surg Oncol. 2022 Apr 19. pii: 10.1245/s10434-022-11773.
    PubMed     Abstract available


  381. KOH HH, Cho ES, Lee JH, Shin SJ, et al
    ASO Visual Abstract: Association Between Albumin-Bilirubin Grade and Myosteatosis and Its Prognostic Significance for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2022 Apr 5. pii: 10.1245/s10434-022-11552.
    PubMed    


  382. ROUANET P, Selvy M, Jarlier M, Bugnon C, et al
    Tailored Management with Highly-Selective Diversion for Low Colorectal Anastomosis: Biochemical Postoperative Follow-Up and Long-Term Results from a Single-Institution Cohort.
    Ann Surg Oncol. 2022;29:2514-2524.
    PubMed     Abstract available


  383. TAKEDA Y, Mise Y, Takahashi Y, Ito H, et al
    Limited Prognostic Value of KRAS in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:2383-2391.
    PubMed     Abstract available


  384. NIE RC, Chen GM, Yuan SQ, Kim JW, et al
    Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:2324-2331.
    PubMed     Abstract available


  385. ERSTAD DJ, Dasari A, Taggart MW, Kaur H, et al
    Prognosis for Poorly Differentiated, High-Grade Rectal Neuroendocrine Carcinomas.
    Ann Surg Oncol. 2022;29:2539-2548.
    PubMed     Abstract available


  386. EADS JR
    Is it Time Yet for Adjuvant Immunotherapy for Patients with DNA Mismatch Repair Deficient Gastric Cancer?
    Ann Surg Oncol. 2022;29:2141-2143.
    PubMed    


  387. ROUANET P, Selvy M, Jarlier M, Bugnon C, et al
    ASO Visual Abstract: Tailored Management with Highly Selective Diversion for Low Colorectal Anastomosis-Biochemical Postoperative Follow-Up and Long-Term Results from a Single-Institution Cohort.
    Ann Surg Oncol. 2022;29:2525-2526.
    PubMed    


  388. MANGIERI CW, Moaven O, Valenzuela CD, Erali RA, et al
    ASO Visual Abstract: Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:2651.
    PubMed    


  389. TAKEDA Y, Mise Y, Takahashi Y, Ito H, et al
    ASO Visual Abstract: Limited Prognostic Value of KRAS for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:2392.
    PubMed    


  390. NIE R, Kim JW, Chen G, Li YF, et al
    ASO Author Reflections: Adjuvant Chemotherapy Should not be Omitted for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability.
    Ann Surg Oncol. 2022;29:2332-2333.
    PubMed    


    March 2022
  391. TANG W, Liu Y, Ji M, Liu T, et al
    Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases.
    Ann Surg Oncol. 2022 Mar 17. pii: 10.1245/s10434-021-11302.
    PubMed     Abstract available


  392. LEE SJ, Kang J, Baik SH, Park EJ, et al
    ASO Visual Abstract: Impact of Mitomycin-C-Induced Neutropenia After Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2022 Mar 7. pii: 10.1245/s10434-022-11493.
    PubMed    


  393. SEBAI A, Tzedakis S, Livin M, Sulpice L, et al
    Prosthetic Reconstruction of the Cavo-Hepatic Venous Confluence for a Colorectal Cancer Liver Recurrence.
    Ann Surg Oncol. 2022 Mar 3. pii: 10.1245/s10434-022-11378.
    PubMed    


  394. MARCHEGIANI F, Palatucci V, Capelli G, Guerrieri M, et al
    Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
    Ann Surg Oncol. 2022;29:1880-1889.
    PubMed     Abstract available


  395. LAW CK, Stevenson ARL, Solomon M, Hague W, et al
    Healthcare Costs of Laparoscopic versus Open Surgery for Rectal Cancer Patients in the First 12 Months: A Secondary Endpoint Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT).
    Ann Surg Oncol. 2022;29:1923-1934.
    PubMed     Abstract available


  396. POLDERDIJK MCE, Brouwer M, Haverkamp L, Ziesemer KA, et al
    Outcomes of Combined Peritoneal and Local Treatment for Patients with Peritoneal and Limited Liver Metastases of Colorectal Origin: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:1952-1962.
    PubMed     Abstract available


  397. NIZRI E, Berger Y, Green E, Kyzer M, et al
    Lymph Node Metastases from Visceral Peritoneal Colorectal Metastases are Associated with Systemic Recurrence.
    Ann Surg Oncol. 2022;29:2069-2075.
    PubMed     Abstract available


  398. BURGHGRAEF TA, Hol JC, Rutgers ML, Crolla RMPH, et al
    Laparoscopic Versus Robot-Assisted Versus Transanal Low Anterior Resection: 3-Year Oncologic Results for a Population-Based Cohort in Experienced Centers.
    Ann Surg Oncol. 2022;29:1910-1920.
    PubMed     Abstract available


  399. CUI CL, Luo WY, Cosman BC, Eisenstein S, et al
    Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation.
    Ann Surg Oncol. 2022;29:1894-1907.
    PubMed     Abstract available


  400. MARCHEGIANI F, Palatucci V, Capelli G, Guerrieri M, et al
    ASO Visual Abstract: Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
    Ann Surg Oncol. 2022;29:1892-1893.
    PubMed    


  401. PEREZ RO
    Cost-Effectiveness of Watch and Wait: What is in the Box of this Organ-Preservation Strategy?
    Ann Surg Oncol. 2022;29:1516-1517.
    PubMed    


  402. MARCHEGIANI F, Spolverato G, Pucciarelli S
    ASO Author Reflections: Rectal Preservation After Major or Complete Clinical Response to Neoadjuvant Therapy-The Safety of Integrated Approaches.
    Ann Surg Oncol. 2022;29:1890-1891.
    PubMed    


  403. GOFFREDO P, Smith JJ
    The Paradox of Early Stage Rectal Cancer: More ReSeARCh in the Right Direction.
    Ann Surg Oncol. 2022;29:1513-1515.
    PubMed    


  404. WEISER MR
    Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: PRODIGE 23 Trial.
    Ann Surg Oncol. 2022;29:1493-1495.
    PubMed    


  405. CUI CL, Luo WY, Cosman BC, Eisenstein S, et al
    ASO Author Reflections: Bang for Your Buck-Implications of the Cost-Effectiveness of Watchful Waiting Versus Radical Surgery for Locally Advanced Rectal Cancer After Successful Neoadjuvant Chemoradiation.
    Ann Surg Oncol. 2022;29:1908-1909.
    PubMed    


    February 2022
  406. KOH HH, Kang J
    ASO Author Reflections: Albumin-Bilirubin Grade and Myosteatosis as Potential Cancer Cachexia-Related Indicators in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2022 Feb 26. pii: 10.1245/s10434-022-11489.
    PubMed    


  407. SEBAI A, Boudjema K
    ASO Author Reflections: Resection of Colorectal Cancer Liver Metastasis with Vascular Invasion.
    Ann Surg Oncol. 2022 Feb 26. pii: 10.1245/s10434-022-11459.
    PubMed    


  408. KOH HH, Cho ES, Lee JH, Shin SJ, et al
    Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2022 Feb 24. pii: 10.1245/s10434-022-11445.
    PubMed     Abstract available


  409. KIM JK, Thompson H, Jimenez-Rodriguez RM, Wu F, et al
    Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.
    Ann Surg Oncol. 2022;29:1172-1179.
    PubMed     Abstract available


  410. KROON HM, Dudi-Venkata NN, Bedrikovetski S, Liu J, et al
    Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases.
    Ann Surg Oncol. 2022;29:1194-1203.
    PubMed     Abstract available


  411. SIMUNOVIC M, Grubac V, Hillis C, Yang I, et al
    Identification and Adjudication of Adverse Events Following Rectal Cancer Surgery: Observational Case Series in a Region of Ontario, Canada.
    Ann Surg Oncol. 2022;29:1182-1191.
    PubMed     Abstract available


  412. PAMEIJER CR
    HIPEC Trials and the US: A Review and Call to Action.
    Ann Surg Oncol. 2022;29:866-872.
    PubMed    


  413. KIM JK, Garcia-Aguilar J
    ASO Author Reflections: Identifying Rectal Cancer Patients Suitable for Watch-and-Wait.
    Ann Surg Oncol. 2022;29:1180.
    PubMed    


  414. KROON HM, Kusters M, Sammour T
    ASO Author Reflection: Lateral Pelvic Lymph Nodes in Rectal Cancer-Not All Are Created Equal.
    Ann Surg Oncol. 2022;29:1204-1205.
    PubMed    


    January 2022
  415. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    ASO Author Reflections: Intersectionality of Social Determinants of Health in Lung and Colorectal Cancer Diagnosis and Treatment.
    Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11224.
    PubMed    


  416. KANTERS A, Liska D
    The Impact of Ulcerative Colitis on Colorectal Cancer Prognosis: The Jury is Still Out.
    Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11307.
    PubMed    


  417. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11160.
    PubMed     Abstract available


  418. VERHEIJ FS, Soares KC, Beets GL, Kok NFM, et al
    ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11106.
    PubMed    


  419. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    ASO Visual Abstract: Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jan 3. pii: 10.1245/s10434-021-11247.
    PubMed    


  420. DUMONT F, Barreteau T, Simon G, Loaec C, et al
    Laparoscopic Extraperitoneal Approach to Bilateral Pelvic Lymph Node Dissection in Low Rectal Cancer: Technique with Video and 3D Modeling.
    Ann Surg Oncol. 2022;29:109-111.
    PubMed     Abstract available


  421. YAMADA S, Takiyama H, Isozaki Y, Shinoto M, et al
    Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer of Patients with Prior Pelvic Irradiation.
    Ann Surg Oncol. 2022;29:99-106.
    PubMed     Abstract available


  422. GARCIA-FADRIQUE A, Estevan Estevan R, Sabater Orti L
    Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:188-202.
    PubMed     Abstract available


  423. YAMADA S, Takiyama H, Isozaki Y, Shinoto M, et al
    ASO Visual Abstract: Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer in Patients with Prior Pelvic Irradiation.
    Ann Surg Oncol. 2022;29:107-108.
    PubMed    


  424. NOTICEWALA SS, Das P
    Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer.
    Ann Surg Oncol. 2022;29:11-12.
    PubMed    


  425. GARCIA-FADRIQUE A
    ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results?
    Ann Surg Oncol. 2022;29:203-204.
    PubMed    


  426. RAOOF M, Dellinger T
    ASO Author Reflections: Defining the Role of PIPAC in the Treatment of Peritoneal Metastases.
    Ann Surg Oncol. 2022;29:186-187.
    PubMed    


    December 2021
  427. KEMPER M, Izbicki JR, Reeh M
    Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer?
    Ann Surg Oncol. 2021;28:8020-8021.
    PubMed    


  428. BRAC B, Dufour C, Behal H, Vanderbeken M, et al
    Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer?
    Ann Surg Oncol. 2021;28:8337-8346.
    PubMed     Abstract available


  429. BROHOLM M, Degett TH, Furbo S, Fiehn AK, et al
    Colonic Stent as Bridge to Surgery for Malignant Obstruction Induces Gene Expressional Changes Associated with a More Aggressive Tumor Phenotype.
    Ann Surg Oncol. 2021;28:8519-8531.
    PubMed     Abstract available


  430. GIULIANTE F, Vigano L, De Rose AM, Adam R, et al
    ASO Author Reflections: The Liver-First Approach: A New Standard for Patients with Multiple Bilobar Colorectal Metastases?
    Ann Surg Oncol. 2021;28:8209-8210.
    PubMed    


  431. SHIN JK, Park YA, Huh JW, Yun SH, et al
    Tumor Budding as a Prognostic Marker in Rectal Cancer Patients on Propensity Score Analysis.
    Ann Surg Oncol. 2021;28:8813-8822.
    PubMed     Abstract available


  432. RIESER CJ, Jones H, Hall LB, Kang E, et al
    Definition and Prediction of Early Recurrence and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: Towards Predicting Oncologic Futility Preoperatively.
    Ann Surg Oncol. 2021;28:9116-9125.
    PubMed     Abstract available


  433. GIULIANTE F, Vigano L, De Rose AM, Mirza DF, et al
    Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry.
    Ann Surg Oncol. 2021;28:8198-8208.
    PubMed     Abstract available


  434. BRAHMBHATT RD, Tee MC, Franko J
    Robotic Isolated Caudate Lobectomy for Solitary Colorectal Liver Metastasis.
    Ann Surg Oncol. 2021;28:8236-8237.
    PubMed     Abstract available


  435. BAKKERS C, Lurvink RJ, Rijken A, Nienhuijs SW, et al
    Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.
    Ann Surg Oncol. 2021;28:9073-9083.
    PubMed     Abstract available


  436. JIANG W, Li M, Tan J, Feng M, et al
    ASO Visual Abstract: A Nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
    Ann Surg Oncol. 2021;28.
    PubMed    


  437. BAKKERS C, Lurvink RJ, Rijken A, Nienhuijs SW, et al
    ASO Visual Abstract: Treatment Strategies and Prognosis in Patients with Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.
    Ann Surg Oncol. 2021;28.
    PubMed    


  438. VEGA EA, Salehi O, Conrad C
    ASO Visual Abstract: Failure to Cure Patients with Colorectal Liver Metastases-The Impact of the Liver Surgeon.
    Ann Surg Oncol. 2021;28.
    PubMed    


  439. JAYME VR, Fonseca GM, Amaral IMA, Coelho FF, et al
    ASO Visual Abstract: Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size?
    Ann Surg Oncol. 2021;28.
    PubMed    


  440. GOLDBERG EM, Berger Y, Sood D, Kurnit KC, et al
    ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer.
    Ann Surg Oncol. 2021;28.
    PubMed    


  441. SAWADA R, Akiyoshi T, Kitagawa Y, Hiyoshi Y, et al
    ASO Visual Abstract: Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Ann Surg Oncol. 2021;28.
    PubMed    


  442. WIJSMULLER AR, Hemmer PHJ
    Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer.
    Ann Surg Oncol. 2021;28.
    PubMed    


  443. KONG JC, Ngan S, Tie J, Heriot AG, et al
    Reply to: Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not.
    Ann Surg Oncol. 2021;28.
    PubMed    


  444. SOCHA J, Bujko K
    Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not.
    Ann Surg Oncol. 2021;28.
    PubMed    


  445. BAKKERS C, Lurvink RJ, van Erning FN, Nienhuijs SW, et al
    ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:9084-9085.
    PubMed    


  446. LINTIS A, Piessen G, Eveno C
    Together or Sequentially? A Curative Approach of Colorectal Liver and Peritoneal Metastasis Treatment is Possible.
    Ann Surg Oncol. 2021;28.
    PubMed    


  447. ADILEH M, Laks S, Ben-Yaakov A, Nissan A, et al
    Response to: Concurrent or Sequential? A Curative Approach to Colorectal Liver and Peritoneal Metastasis Treatment is Possible.
    Ann Surg Oncol. 2021;28.
    PubMed    


  448. HUISMAN JF, de Vos Tot Nederveen Cappel WH, van Westreenen HL
    ASO Author Reflections: Decline in Unnecessary Surgery by Structural Restaging After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2021;28.
    PubMed    


    November 2021
  449. VERHEIJ FS, Yuval JB, Soares KC, Garcia-Aguilar J, et al
    ASO Author Reflections: Hepatic Arterial Infusion Pump Can Be Placed Simultaneously with Primary Tumor Resection in Colon Cancer Patients with Synchronous Metastases.
    Ann Surg Oncol. 2021 Nov 17. pii: 10.1245/s10434-021-11043.
    PubMed    


  450. MARKS VA, Hsiang WR, Umer W, Haleem A, et al
    Access to Colorectal Cancer Care for Medicaid-Insured Patients at Designated Cancer Facilities.
    Ann Surg Oncol. 2021 Nov 11. pii: 10.1245/s10434-021-11053.
    PubMed    


  451. VERHEIJ FS, Soares KC, Beets GL, Kok NFM, et al
    Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.
    Ann Surg Oncol. 2021 Nov 9. pii: 10.1245/s10434-021-11029.
    PubMed     Abstract available


  452. ZORRILLA-VACA A, Ripolles-Melchor J, Fernandez-Valdes P, Ruiz-Escobar A, et al
    Association of Liberal Fluid Therapy for Colorectal Cancer Surgery and Long-Term Oncologic Recurrence.
    Ann Surg Oncol. 2021 Nov 8. pii: 10.1245/s10434-021-11046.
    PubMed    


  453. LIU W, Zhang W, Xu Y, Li YH, et al
    A Prognostic Scoring System to Predict Survival Outcome of Resectable Colorectal Liver Metastases in this Modern Era.
    Ann Surg Oncol. 2021;28:7709-7718.
    PubMed     Abstract available


  454. GOLDBERG EM, Berger Y, Sood D, Kurnit KC, et al
    Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer.
    Ann Surg Oncol. 2021;28:7795-7806.
    PubMed     Abstract available


  455. VEGA EA, Salehi O, Nicolaescu D, Dussom EM, et al
    Failure to Cure Patients with Colorectal Liver Metastases: The Impact of the Liver Surgeon.
    Ann Surg Oncol. 2021;28:7698-7706.
    PubMed     Abstract available


  456. VAN LOON YT, van Erning FN, Maas HA, Stassen LPS, et al
    Primary Anastomosis Versus End-Ostomy in Left-Sided Colonic and Proximal Rectal Cancer Surgery in the Elderly Dutch Population: A Propensity Score Matched Analysis.
    Ann Surg Oncol. 2021;28:7450-7460.
    PubMed     Abstract available


  457. KONG JC, Soucisse M, Michael M, Tie J, et al
    Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.
    Ann Surg Oncol. 2021;28:7476-7486.
    PubMed     Abstract available


  458. JAYME VR, Fonseca GM, Amaral IMA, Coelho FF, et al
    Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size?
    Ann Surg Oncol. 2021;28:7636-7646.
    PubMed     Abstract available


  459. WILSON K, Heriot A
    ASO Author Reflections: Immunotherapy in Rectal Cancer Illusion or Nirvana.
    Ann Surg Oncol. 2021;28:7474-7475.
    PubMed    


  460. VEGA EA, Freeman R, Conrad C
    Do We Still Need Liver Surgeons in the Treatment of Colorectal Liver Metastases?
    Ann Surg Oncol. 2021;28:7707-7708.
    PubMed    


  461. SQUEO GC, Kane WJ, Hedrick TL
    Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERP and Colorectal Cancer Surgery.
    Ann Surg Oncol. 2021;28:6974-6977.
    PubMed    


    October 2021
  462. CHAN AKC, Mason JM, Baltatzis M, Siriwardena AK, et al
    Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC).
    Ann Surg Oncol. 2021 Oct 30. pii: 10.1245/s10434-021-11017.
    PubMed     Abstract available


  463. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Visual Abstract: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10942.
    PubMed    


  464. KONISHI T, Rodriguez-Bigas MA
    Primary Tumor Resection in Colorectal Cancer with Unresectable Synchronous Metastasis: Time to Reconsider the Role of the Surgeon.
    Ann Surg Oncol. 2021 Oct 20. pii: 10.1245/s10434-021-10949.
    PubMed    


  465. LEE SJ, Jeon Y, Lee HW, Kang J, et al
    Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2021 Oct 19. pii: 10.1245/s10434-021-10924.
    PubMed     Abstract available


  466. FLOOD M, Narasimhan V, Wilson K, Lim WM, et al
    ASO Visual Abstract: Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer-A Systematic Review.
    Ann Surg Oncol. 2021 Oct 18. pii: 10.1245/s10434-021-10926.
    PubMed    


  467. FROMER MW, Scoggins CR, Egger ME, Philips P, et al
    ASO Visual Abstract: Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer.
    Ann Surg Oncol. 2021 Oct 4. pii: 10.1245/s10434-021-10841.
    PubMed    


  468. FLOOD M, Narasimhan V, Wilson K, Lim WM, et al
    Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10829.
    PubMed     Abstract available


  469. HIDA K, Nishizaki D, Sumii A, Okamura R, et al
    Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
    Ann Surg Oncol. 2021;28:6179-6188.
    PubMed     Abstract available


  470. JIANG W, Li M, Tan J, Feng M, et al
    A Nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
    Ann Surg Oncol. 2021;28:6408-6421.
    PubMed     Abstract available


  471. SAWADA R, Akiyoshi T, Kitagawa Y, Hiyoshi Y, et al
    Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Ann Surg Oncol. 2021;28:6189-6198.
    PubMed     Abstract available


  472. THIAGARAJAN S, Tan JW, Zhou S, Tan QX, et al
    Postoperative Inflammatory Marker Surveillance in Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2021;28:6625-6635.
    PubMed     Abstract available


  473. ROSATI A, Vargiu V, Santullo F, Lodoli C, et al
    Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery.
    Ann Surg Oncol. 2021;28:6721-6722.
    PubMed     Abstract available


  474. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10864.
    PubMed    


  475. CHOI GS
    Lateral Pelvic Node Metastasis in Locally Advanced Rectal Cancer: Are We Exaggerating or Ignoring?
    Ann Surg Oncol. 2021;28:5803-5804.
    PubMed    


  476. YASHIMA-ABO A, Otsuka K, Nishizuka SS
    Editorial Comment to "A nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients".
    Ann Surg Oncol. 2021;28:5818-5819.
    PubMed    


  477. SAWADA R, Akiyoshi T
    ASO Author Reflections: Combinations of Systemic Inflammatory Markers and CD8+ Tumor-infiltrating Lymphocyte Density: Predictive Utility for Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Ann Surg Oncol. 2021;28:6199-6200.
    PubMed    


  478. TAN JW, Thiagarajan S, Zhou S, Tan QX, et al
    ASO Author Reflections: Postoperative Inflammatory Markers as a Surveillance Tool in Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2021;28:6636-6637.
    PubMed    


  479. JIANG W, Gao Y, Zhuo S, Yan J, et al
    ASO Author Reflections: Prediction of Treatment Response to Neoadjuvant Chemoradiotherapy Based on a Collagen Features Model in Rectal Cancer Patients.
    Ann Surg Oncol. 2021;28:6422-6423.
    PubMed    


  480. MUADDI H, Karanicolas P
    ASO Author Reflections: Disappearing Liver Metastases: Should We Be Afraid of the Dark?
    Ann Surg Oncol. 2021;28:6814-6815.
    PubMed    


    September 2021
  481. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among US Counties.
    Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10849.
    PubMed     Abstract available


  482. LIVINGSTON AJ, Bailey CE
    Invited Editorial: Does Side Really Matter? Survival Analysis Among Patients with Right- Versus Left-Sided Colon Cancer: A Propensity Score-Adjusted Analysis.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-020-09522.
    PubMed    


  483. ROMESSER PB, Crane CH
    Chemo-Re-Irradiation and Salvage Surgery for Locally Recurrent Rectal Cancer.
    Ann Surg Oncol. 2021;28:4769-4771.
    PubMed    


  484. CEELEN W
    Intraperitoneal EpCAM-Targeted Immunotoxin: A First Step Towards Engineering the Immune Environment in Colorectal Peritoneal Metastases?
    Ann Surg Oncol. 2021;28:4772-4774.
    PubMed    


  485. FLANAGAN M, Clancy C, Burke J
    ASO Author Reflections: Clinical Benefit of Neoadjuvant Short-Course Radiotherapy for Upper-Third Rectal Tumors over Surgery Alone.
    Ann Surg Oncol. 2021;28:5250-5251.
    PubMed    


  486. LAKS S, Adileh M, Ben-Yaacov A, Nissan A, et al
    ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:5339-5340.
    PubMed    


  487. ROVERS KP, Lurvink RJ, Nienhuijs SW, de Hingh IHJT, et al
    ASO Author Reflections: PIPAC for Unresectable Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:5327-5329.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.